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ABSTRACT
The present study investigated the distribution of the vasotocin subtype four receptor (VT4R)
in brain and pituitary gland of the chicken, Gallus gallus. The anterior pituitary cell types
associated with the VT4R were also determined. Two polyclonal antibodies were raised in rabbit
against a cocktail of peptides, 15 amino acids from the amino terminal region and 17 amino acids
from the carboxy terminal region of VT4R receptor. The antibody was validated utilizing the
Western blot and immunocytochemistry. A single band at 47KDa utilizing membrane protein
extracts of chicken brain and pituitary tissues was shown for the VT4R antibody. A peptide
preadsorption or blocking experiment was performed to confirm the specificity of the antibody to
the VT4R. Second, the VT4R distribution in brain and pituitary were studied using
immunocytochemistry. The VT4R antibody immunostained both neuronal and non-neuronal
elements present in the brain. The VT4R was widely distributed throughout the brain. Intense
cell body staining was observed in the following neural structures:

supraoptic nucleus,

paraventricular nucleus, periventricular hypothalamic nucleus, Edinger Westphal and other
oculomotor nuclei, nucleus tractus solitarius, hypoglossal nucleus, trigeminal nucleus, sensory
nucleus of the trigeminal nerve, nucleus of the abducens nerve, nucleus supraspinalis and
magnocellular cochlear nucleus.

Intense immunoreactivity of the VT4R in glial cells was

evident in circumventricular organs.

Radial glial cells in hippocampus, astrocytes in optic

tectum and tanycytes in median eminence were prominently immunostained with the VT4R. In
addition, the regional distribution of the VT4R was determined in the pituitary gland of the
chicken. The VT4R was located in the cephalic lobe of the anterior pituitary. The phenotype of
pituitary cells was revealed using dual labelled immunofluorescence microscopy. The VT4R
immunoreactive cells were located in both corticotropes and gonadotropes. About 89% and 12%
of corticotropes and luteinizing hormone (LH) containing gonadotropes, respectively, displayed

the VT4R.

The VT4R was not detected in lactotropes nor somatotropes.

Based on its

neuroanatomical distribution in brain and colocalization studies of the VT4R in anterior
pituitary, the proposed functions of the VT4R was suggested to be associated with stress
responses, maintenance of homeostasis and lutenizing hormone release from a subgroup of
pituitary gonadotropes. The receptor could also have a plausible role in auditory function and
motor regulation of the eye based upon intense immunoreactivity of neurons associated with the
fifth and third cranial nerves, respectively.
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I.

INTRODUCTION
The survival of a species depends on its adaptative responses to stressful (challenging and

threatening) situations (Ulrich-Lai and Herman, 2009).

The brain is the key organ that

distinguishes threatening and non-threatening situations and determines the physiological
responses to situations (McEwen, 2007).

The stress response includes the suppression of

activities like feeding which are not important for short-term survival. In response to stress, the
neuroendocrine and autonomic nervous system together undergo changes to restore the disturbed
homeostasis. The sympathetic arm of the autonomic nervous system coupled with activation of
the adrenal medulla and the hypothalamic pituitary adrenal axis (HPA) aid in bidirectional
communication between brain and body in response to adverse situations (Engelmann et al.,
2004). The autonomic nervous system helps in the immediate response to stressors through
sympathetic and parasympathetic nerve activity. The preganglionic neurons of the sympathetic
nervous system act on the adrenal medulla to release epinephrine and norepinephrine. Under
stressful conditions, the animal shows a flight or fight response that includes dilation of pupils,
shunting of blood to voluntary muscles and release of energy through gluconeogenesis. The
energy is further provided to the animal by stimulating fatty acid release, enhancing glucose
utilization and inhibiting protein synthesis (Bear et al., 2001). The slower more prolonged
response of stress follows activation of the HPA axis. In response to a stressor, the parvocellular
neurons of the paraventricular nucleus (PVN) and supraoptic nucleus (SON) of the hypothalamus
secrete the nine-amino acid peptide, arginine vasopressin (AVP) and 41 amino acid polypeptide,
corticotropin releasing hormone (CRH) into the portal circulation.

The neuropeptides are

transported to anterior pituitary. The corticotropes present in anterior pituitary subsequently
secrete adrenocorticotropin releasing hormone (ACTH) in response to binding of the peptides to
specific receptors and initiation of specific signal transduction pathways. The hormone, ACTH,
1

in turn acts on the adrenal cortex in mammals and inter-renal tissue of adrenal glands in birds to
produce glucocorticoids, cortisol in humans and corticosterone in birds (Engelmann et al.,
2004; Volpi et al., 2004; McEwen, 2007; Aguilera et al., 2008; Kuenzel and Jurkevich, 2009;
Ulrich-Lai and Herman, 2009).
Arginine vasopressin (AVP) and corticotropin releasing hormones (CRH) are two critical
peptides involved in neuroendocrine regulation. Both hormones act on their target tissues via G
protein coupled receptors. In birds, the CRH neurohormone is a 41 amino acid long peptide
which is identical to CRH of human and rats. Corticotropin releasing hormone exerts its effects
through corticotropin releasing hormone receptor subtypes: CRH1 and CRH2 (Vandenborne et
al., 2005; Mikhailova et al., 2007). Arginine Vasotocin (AVT) is the avian counterpart of
arginine vasopressin. Avian AVT differs from AVP in the third amino acid of the molecule
where isoleucine (Ile) is replaced by phenylalanine (Phe). In mammals, AVP exerts it effects via
vasopressin (V) receptor subtypes: V1a, V1b and V2 receptors.

Vasopressin 1a and V1b

receptors activate phospolipase C through coupling of Gαq/11 and V2 receptors couple to Gs and
activate adenylate cyclase (Birnbaumer, 2000; Robert and Clauser, 2005).
Studies on vasotocin receptors in non mammalian species like frogs (Acharjee et al., 2004),
chickens (Tan et al., 2000; Cornett et al., 2003; Baeyens and Cornett, 2006; Gubrij et al., 2005;
Jurkevich et al., 2005; Jurkevich et al., 2008), newts Hasunuma et al., 2007; Hasunuma et al.,
2010) and fish have been reported (Warne, 2001; Kline et al., 2011). In chickens, the vasotocin
receptors are of four known subtypes: VT1R, VT2R, VT3R and VT4R. Molecular studies of the
genes have focused on VT1R, VT2R and VT3R. The first receptor, VT1R is present in shell
gland (confined to endometrial lining) and brain, involved in reproductive/maternal behavior and
contraction of smooth muscles in uterus and proposed to be homologous to the V2 receptor in
2

humans (Tan et al., 2000). The second receptor, VT2R is present in the cephalic lobe of the
anterior pituitary gland. The major function of the VT2R is to release ACTH and corticosterone
during stress responses and is proposed to be homologous to the mammalian V1b receptor (Tan
et al., 2000; Cornett et al., 2003; Jurkevich et al., 2005; Baeyens and Cornett, 2006). The third
receptor, VT3R, has been shown to occur in the endometrium and myometrium of the shell gland
indicating a plausible role in stimulating uterine contraction during oviposition. The receptor is
proposed to be homologous to the oxytocin receptor in humans (Gubrij et al., 2005). The
receptor, VT4R is a recent cloned receptor which shares 69% similarity with the mammalian
V1a receptor (Cornett et al., 2007, Genebank submission). The receptor might be involved in
stress responses and in regulation of water and blood pressure (Baeyens and Cornett, 2006). To
date, a study examining the distribution of the VT4R in neural systems and its functional role in
chickens have not yet been reported. A study was therefore conducted to determine if the VT4R
is present in brain and pituitary gland of the chicken and possibly associated with the stress
response.
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II. LITERATURE REVIEW
Chapter 1
Arginine vasopressin/Arginine vastocin and its receptors
1.1. Arginine vasopressin and its function
1.1.1 Arginine vasopressin
Arginine vasopressin (AVP) is a neuropeptide secreted by neurons of the supraoptic (SON)
and paraventricular nuclei (PVN) in the hypothalamus. The vasopressinergic neurons originate
from the ventral region of supraoptic nucleus and central region of the paraventricular nucleus of
mammals (Vandesande et al., 1977). On proper stimulation, AVP is synthesized and released by
one of two types of neurons found in the neural systems: (i) magnocellular system where
vasopressin is released into axon terminals in the neural lobe of pituitary and (ii) parvocellular
system where axons project to the external zone of the median eminence and AVP is released
into the portal circulation on appropriate stimulus activation and transported to the anterior
pituitary (Engelmann et al., 2004; Aguilera et al., 2008). Vasopressin is present in both internal
and external zones of the median eminence. The magnocellular axons from PVN containing
vasopressin pass through the internal zone of median eminence and terminate in the posterior
pituitary (Holmes et al., 1986). Herring bodies are neurosecretory bodies found in the posterior
pituitary that store vasopressin temporarily and release it into the bloodstream on hypothalamic
stimulation (Vandesande et al., 1977). The parvocellular neurons from the paraventricular
nucleus project to the external zone of median eminence. The neuropeptides are transported to
the pituitary which secretes adrenocorticotropic releasing hormone (ACTH) from corticotropes
of the anterior pituitary. The ACTH hormone acts on the adrenal cortex in mammals (Figure. 1)
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and adrenal interrenal tissue in birds to release gluocorticoids (Engelmann et al., 2004; Volpi et
al., 2004).

Figure 1: Functional anatomical components of Hypothalamo-pituitary adrenal axis.

CRF:

Corticotropin releasing factor, AVP: Arginine vasopressin, ACTH: Adrenocorticotropic
hormone, I.H.: inferior hypophysial, S.H.: superior hypophysial (Turnbull and Rivier, 1999).
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1.1.2 Arginine vasopressin gene:
The vasopressin gene has the following components: a signal peptide, vasopressin precursor,
preprovasopressin, neurophysin II and copeptin.

Neurophysin II helps vasopressin to be

packaged as secretory granules while vasopressin domain (association of vasopressin and
neurophysin) aids in trafficking of the prehormone to the secretory pathway. This AVP gene is
regulated negatively by glucocorticoids at the protein level (Itoi et al., 2004).

1.1.3 Role of Arginine Vasopressin:
Arginine vasopressin regulates body fluid volume, homeostasis, vasoconstriction and release
of ACTH in stress responses (Fahrenholz et al., 1993). Vasopressin plays an important role in
hypothalamic pituitary adrenal axis adaptation to chronic stress but not for the sensitization of
ACTH responses to a novel stress observed when the animal is in chronic stress (Aguilera et al.,
2008). During acute stress, there is an immediate release of CRH and VP from parvocellular
neurons of PVN to pituitary. In chronic stress, CRH is released first followed by delayed and
prolonged response of VP. Glucocorticoids inhibit CRH followed by VP in chronic stress. In
adrenalectomized rats subsequently administered glucocorticoids, the inhibition of the VP gene
is preferred over CRH gene during stress responses. Glucocorticoids provide a negative feedback
by acting on multiple sites inhibiting VP and CRH actions and indirectly acting on neural
pathways of GABAergic neurons. The number of V1bR increases in anterior pituitary during
acute stress due to gene transcription of V1bR.

The key component in regulating V1bR

expression is 5’ UTR (untranslated region) of the gene (Volpi et al., 2004).

Vasopressin

receptors play a critical role in corticotrope function. In mammals, AVP receptors (V1 type) in
pituitary are downregulated during chronic osmotic stimulation while upregulated during
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repeated intra peritoneal injections or repeated immobilization. The V1 type receptors fluctuates
with the number of binding sites during up- or down- regulation of the receptors, however, there
is no change in the binding affinity of the receptors (Aguilera et al., 1994). Vasopressin aids in
water regulation through the subfornical organ (SFO), choroid plexus, organum vasculosum of
the lamina terminalis (OVLT) that are labelled for AVP receptors. The structures SFO and
OVLT are involved in thirst control in both rats and birds (Fahrenholz et al., 1993). Arginine
vasopressin also plays a behavioral role in aggression, social recognition, affiliation, anxiety and
depression, spatial and non-spatial memory (Caldwell et al., 2008). Arginine vasopressin via
V1aR acts on lateral septum which inturn receives inputs from olfactory vomeronasal system and
thus helps in social recognition. Offspring recognition in sheep and pair bonding in prairie voles
are examples of social recognition in animals where AVP has a major impact. The lateral septum
also modulates anxiety in mice. (Bielsky and Young, 2004).
Vasopressin/vasotocin function as a neurohormone peripherally by mediating the release of
hormones both in vivo and in vitro. In the ovine pituitary gland, AVP and CRH regulate ACTH
secretion in vitro (Smith et al., 1993). The release of prolactin (PRL) from anterior pituitary
gland was stimulated by AVP/AVT when injected subcutaneously in rats (Blask et al., 1982;
Blask et al., 1984) while AVP/AVT stimulated PRL and luteinzing hormone release in vitro
(Vaughan et al., 1975). Angiotensin II, CRF, and AVP act as positive stimulator for ACTH
secretion in rat AtT-20 cell lines. Epinephrine, AVP and CRH stimulate POMC gene expression
in a time and dose related manner in rat cells (Aoki et al., 1997). Both AVP and AVT stimulate
both α-MSH and ACTH in perfused pituitary cells of ducks. These peptides act synergistically
on the corticomelanotropic cells to release hormones (Castro et al., 1986; Castro et al., 1988).
The release of prolactin is stimulated by AVT in turkey anterior pituitary cell cultures while
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AVT mediates PRL release in chickens (Proudman and Opel, 1988; Jurkevich et al., 2008). In
frogs, ACTH release is stimulated by CRF and AVP in anterior pituitary cells (in vitro) (Tonon
et al., 1986). In trout, CRH and AVT act synergistically to stimulate ACTH release. This
synergistic mechanism has an added advantage that there is an increased flexibility over ACTH
control as the two peptides are produced by independent genes (Baker et al, 1996). Synergistic
increases in the release of plasma corticosterone following injections of AVT and CRH in the
chicken have been reported (Madison et al., 2008).

1.2 Arginine vasopressin/vasotocin receptors:
Arginine vasopressin exerts its effect through vasopressin receptors (V) and oxytocin (OT)
receptors. Vasopressin receptors are G protein coupled receptors and are divided into three
subtypes: V1a, V1b and V2. The vasopressin receptors, V1a and V1b couple to Gαq/11 GTP
binding proteins and activate phosopholipase C (Caldwell et al., 2008). The magnocellular
neurons secreting vasopressin display vasopressin receptors, V1a and V1b receptor subtypes
(Hurbin et al., 1998; Hurbin et al., 2002).
In non-mammalian vertebrates, the neurohypophysial hormones arginine vasotocin (AVT)
and mesotocin (MT) are counterparts of mammalian arginine vasopressin (AVP) and oxytocin
(OT), respectively. It was found that the non-mammalian vertebrates have arginine vasotocin
(AVT) instead of vasopressin, having an amino acid substitution at the third position with
phenylalanine (Phe) being replaced by isoleucine (Ile) (Acher et al., 1970). Arginine vasotocin
is involved in various behavioural functions like scent marking, aggression, vocal
communication, stress, social recognition and sexual behaviour (Goodson, 1998).

The

neuropeptides, AVT and MT are activated through G protein coupled receptors (GPCR)
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through the phospholipase C/protein kinase C pathway. The receptors belong to the
vasotocin/mesotocin subfamily.

Vasotocin receptors (VT) have been identified in birds, frogs

and newts that are comparable to vasopressin receptors (AVP) of mammals based on
conservation of their amino acid residues of the respective peptides across vertebrate species.
The comparable nomenclature of mammalian and non-mammalian species is shown in Table 1.
Table 1: Designation of vasopressin/vasotocin (AVP/AVT)
oxytocin/mesotocin (OT/MT) receptors across vertebrate species
CLASS/
SPECIES
Human
Rat

AVT/AVP
RECEPTOR 1
V1a
V1a

AVT/AVP
RECEPTOR 2
V1b (V3)
V1b (V3)

AVT/AVP
RECEPTOR 3
V2
V2

receptors

OT/MT
RECEPTORS
OT
OT

and

Ref

29, 86
4,66,71,
95
Chicken
VT4
VT2
VT1
VT3
10,29,40,
52, 53, 84
1
2
3
1
Frogs
VT1
V2
MT
1, 2, 56
Newt4
V1a
V1b (V3)
V2
-5
42, 43
6,7
5
Fish
V1a1
V1a2
V2
55, 57
1
Receptor designation was obtained from Rana catesbeiana (Bull frog) and Rana esculenta
(Edible frog)
2
A receptor comparable to mammalian V1b has not been identified in frogs.
3
Receptor designation was obtained from Hyla Japonica (Japanese tree frog).
4
Receptor designation was obtained from Cynops pyrrhogaster (Japanese red bellied newt, an
amphibian).
5
A receptor comparable to mammalian oxytocin receptor has not been identified in newts nor
fish up to this time.
6, 7
Receptor designation was obtained from Epinephelus adscensionis (rock hind fish) and
Cyprinodon nevadensis amargosae (pupfish).

1.2.1 Comparable receptors in other vertebrate classes
Several studies have addressed AVP/AVT receptors in both mammalian and non-mammalian
species. The widely studied species on VT receptors are birds, amphibia and fishes. The
vasotocin receptors are comparable to mammalian vasopressin/oxytocin receptors based on
sequence homology, distribution in body organs and function. (Table 2 -6).
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Table 2: Amino acid sequence identity of AVP/AVT and OT/MT receptors among selected
vertebrates1 compared to rats.
Species

V1a

Rats

V1a

%
identity
100%

V1b

V2

V1b

%
identity
100%

OTR

V2

%
identity
100%

OT

%
identity
100%

Chicken

VT4

69%

VT2

54%

VT1

43%

VT3

76%

Frog
Newt
Teleost
fish

VT1
V1a
V1a1

58%
61%
53%

V1b
V1a2

50%
51%

V2
V2
V2

51%
59%
41%

MT
-

67%
-

Ref
4,66,71,
95
10,29,40
,52,53,
84
1, 2, 56
42, 43
55, 57

1

Rat V1a, V1b, V2 and OT receptors were selected as the standard from which the amino acid
sequence of other vertebrate species were compared. The % identity refers to the degree of
homology to the rat.

Table 3: Comparison of mammalian V1a receptors with non mammalian species based on
receptor distribution in organs and function
Species

Rats

Frog

Newt

Teleost fish

V1aR
Sequence
homology1
Organs

V1a
80

VT1
68

V1a
67

V1a1
59

Brain, pituitary,
liver, kidney

Brain, pituitary

Brain, heart, liver,
kidney, bladder,
testis, ovary

Brain,
pituitary,
gills, testis,
ovary, liver

Physiology
and behavior

Social recognition,
anxiety/depression,
memory, aggression

ACTH release.

Courtship behavior

Aggression,
courtship
behavior

Ref

71, 72, 73, 74

1, 2, 56

42, 43

55, 57

1

The proposed homologous receptor were compared to human V1a receptor (V1aR). The
sequence homology refers to the degree of homology to humans.
Note: The avian VT4R shares 69% homology to human V1aR and proposed to be homologous
to the V1aR in mammals. The distribution of the VT4R in the brain and pituitary is the
objective for this study.
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Table 4: Comparison of mammalian V1b receptors with non- mammalian species based on
receptor tissue and organ distribution and function
Species
V1b
Sequence
homology1
Organs

Rats
V1b
63

VT2
47

V1b
59

Teleost fish
V1a2
50

Brain, pituitary

Pituitary

Pituitary

Brain, heart

Physiology
and behavior

Regulates ACTH
release and CORT
levels.

Release of ACTH
and prolactin

ACTH release.

Aggression and
courtship
behavior

Ref

45, 59, 85

29, 52, 53

43, 43

55, 57

1

Chicken

Newt

The proposed homologous receptors in other vertebrates were compared to the human V1b

receptor (V1bR). The sequence homology refers to the degree of homology to humans.
Table 5: Comparison of mammalian V2 receptor with non-mammalian species based on
receptor distribution in organs and function
Species
V2

Rats
V2

Chicken
VT1

Frog
V2

Newt
V2

Telost fish
V2

Sequence
homology1

86

57

52

50

41

Organs

Kidney

Shell gland,
uterus

Brain

Gills,
heart
and kidney

Function

Enhances
cAMP
mediated
aquaporin for
water
reabsorption
67

Contraction of
uterus muscles

Brain, heart,
kidney, urinary
bladder
Cutaneous
water
reabsorption

Osmotic or
ionic
regulation

56

42, 43

Regulated at
the
hypothalamic
level during
hyperosmotic
conditions
56

Ref

84

1

The proposed homologous receptors were compared to the human V2 receptor (V2R). The
sequence homology refers to the degree of homology to humans.
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Table 6: Comparison of the mammalian OT receptor with non-mammalian species based
on tissue and organ receptor distribution and function
Species
OT
Sequence
homology1
Organs

Rats
OT
91

Chicken
VT3
74

Frog
MT
67

Endometrium, myometrium
of shell gland

Brain and pituitary

Function

Brain, pituitary,
mammary gland and
uterus
Release of prolactin

Oxytocic function in
reproduction

Ref

4

40

Controls the activity
of pituitary
melanotropes
1

1

The proposed homologous receptors based upon amino acid sequence identity to the human OT
receptor (OTR). The sequence homology refers to the degree of homology to humans.

Previous studies in our lab focused on the VT2 receptor (VT2R) in chicken which is an avian
homolog of V1b receptor (V1bR) in mammals. A vasotocin receptor, little studied in chickens
is the VT4R. The VT4R has the highest homology with its mammalian counterpart V1aR when
compared to other receptor subtypes. Furthermore, the distribution of the V1aR in several
species (Table 3) is widespread throughout the body compared to other three subtypes
investigated to date. There have not been published studies on the distribution of receptor
subtypes VT1R, VT3R or VT4R in the chicken brain upto this time. Due to the presence of
V1aR in rat, fish and the amphibian brain, the avian VT4R is a good candidate for its presence in
the chicken brain. The current literature review will focus on distribution of V1aR in mammals
and in non-mammalian species.
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1.3 V1a receptors:
There are two conserved glycosylation sites within the second and third extracellular loop in
V1aR. The receptor V1aR is not o-glycosylated. The two sites that are glycosylated in the N
terminus are asparagine (Asn) 14 and Asn 27, while in the second extracellular loop Asn 198 is
glycosylated. The glycosylation of the V1aR regulates the level of receptor expression at the cell
surface and is responsible for normal receptor expression and efficient folding of proteins. The
glycosylation of the receptor, however, is not required for ligand recognition for the intracellular
signalling pathway or for trafficking of receptor to the cell surface (Hawtin et al., 2001).
The receptor is present in brain and pituitary of several species. The review addresses the
distribution of receptors in pituitary and brain among a few selected species.

1.3.1 Hormones secreted by the pituitary in avian species:
The pituitary gland is connected to the hypothalamus at the base of the brain by the
infundibular stalk.

The pituitary is classified as neurohypophysis and adenohypophysis

beginning at the embryonic level and throughout the adult stage. The two lobes of the pituitary
(adenohypophysis and neurohypophysis) are also connected by a network of blood capillaries
(Singh and Dominic, 1975). The neurohypophysis is derived from the infundibulum while the
adenohypophysis is derived from the Rathke`s pouch. The adenohypophysis in mammals is
further differentiated to form the pars distalis (anterior pituitary), the pars intermedia and the pars
tuberalis. The neurohypophysis forms the posterior pituitary (pars nervosa), infundibular stalk
and median eminence (Scanes, 2000).
The avian pituitary lacks the pars intermedia and hence the adenohypophysis forms the
anterior pituitary gland and the pars tuberalis. The anterior pituitary gland is further divided into
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two lobes: cephalic lobe and caudal lobe (Mikami, 1986; Shin-ichi, 1986; Mikami and
Takahashi, 1987; Scanes, 2000). The anatomy of the hypothalamic-hypophyseal complex and the
hormones secreted by anterior pituitary in avian species are summarized in Figure 2.
The anterior pituitary

comprises

six types of cells: ACTH/α melanocyte stimulating

hormone (αMSH) cells, prolactin cells, growth hormone cells, thyrotropin releasing hormone
cells and, in contrast to mammals, separate gonadal hormone producing cells, namely lutenizing
hormone (LH) and follicle stimulating hormone (FSH) cells.

The hormone, pro-

opiomelanocortin (POMC) is a huge precursor protein that is confined to the cephalic lobe of
pituitary as studied by in situ hybridization (Gerets et al., 2000). Its (POMC) derivatives are
produced in the anterior pituitary gland that includes an N terminal fragment, a joining peptide,
adrenocorticotropin (ACTH) and β endorphin. The adrenocorticotropin further can also be
cleaved to form α MSH and corticotropin like intermediate lobe peptide, peptides that in
mammals would be produced in the pars intermedia (Berghman et al., 1998). The ACTH cells,
prolactin cells and TSH cells are confined to the cephalic lobe while growth hormone is present
in the caudal lobe. The hormones, ACTH and α-MSH are produced from the same cell type,
hence both are confined to the cephalic lobe and the cells are called corticomelanotropes. They
are present in very small clusters of cells or in large masses (Ferrand et al., 1974). Gonadal
hormone producing cells, LH and FSH cells, similar to mammals are spread throughout the
cephalic and caudal lobes (Puebla-Osorio et al., 2002; Proudman et al., 1999).
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Figure 2: Schematic diagram of the avian hypothalamus and anterior pituitary gland. Location of
AVT (solid white shading) and MT (solid black shading) cell bodies based on Bons et al., 1980;
neurosecretory neuron;

blood vessel; POA, Preoptic area;

PVN, paraventricular nucleus, SON, supraoptic nucleus; AVT, Arginine vasotocin; CRF,
Corticotropin releasing hormone; MT, Mesotocin; LH, Luteinizing hormone; FSH, Follicle
stimulating hormone; PRL, Prolactin; ACTH, Adrenocorticotropin hormone; GH, Growth
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hormone; cLHRH-I = GnRH-1, Gonadotropin releasing hormone ; VIP, Vasoactive intenstinal
peptide; TRH, Thryotropin releasing hormone; SRIF, Somatostatin (Reproduced from (Scanes,
2000). LH/FSH cells are separate pituitary cells while ACTH and αMSH are produced from
same cell type.

1.3.2 Distribution of V1a receptor in anterior pituitary among selected vertebrates:
1.3.2.1 V1a receptor in rats:
The V1aR is present in a subset of cells in the anterior pituitary. Immunoreactive V1aRs
were associated in cells containing the gonadal hormones, luteinizing hormone (LH) and follicle
stimulating hormone (FSH). This helps in understanding the role of vasopressin in LH/FSH
regulating pathways including gonadotropin releasing hormone (GnRH) neurons in brain (Orcel
et al., 2002).

1.3.2.2 VT1 receptor in frogs:
The VT1R were present in the distal and intermediate lobes of the amphibian pituitary and
helps in the secretion of ACTH from corticotropes in anterior pituitary (Acharjee et al., 2004a;
Acharjee et al., 2004b).

1.3.2.3 V1a1 receptor in fish:
The receptor distribution V1a1R in the fish pituitary, Epinephelus adscensionis was found in
the proximal pars distalis (Kline et al., 2011). A clone of the vasotocin receptor, V1a1R in the
sucker fish was obtained utilizing a sequence based upon the human V1aR. The homology of
the fish V1a1R to human V1aR was 48% and to the rat V1aR was 60%. The V1a1R was found
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in liver, pituitary, and gills. Based on its distribution, the functions of the receptor were
suggested to be involved in liver metabolism, ACTH secretion and osmoregulation in bony fish
(Mahlmann et al., 1994).

1.4 Distribution of V1a receptor in brain among selected vertebrates:
The V1a receptor is widely distributed throughout the body of vertebrates. Most studies,
however, addressed receptor distribution in the brain and its associated functions therefore the
latter will be emphasized among a few selected mammals and non-mammalian vertebrates.

1.4.1 V1a receptor in humans:
Arginine vasopresssin receptor (V1aR) was cloned in humans and comprises 418 amino acids
that shares 83% similarity to the V1a receptor sequenced in rat liver. It has three glycosylation
sites at asparagine (Asn) 14, Asn 17 and Asn 196, eight threonine and seventeen serine
phosphorylation sites located in third loop of the transmembrane domain of the receptor
(Thibonnier et al., 1994)

1.4.2 V1a receptors in mammals:
In rats, the V1a vasopressin receptor is widely expressed in brain (Aoyagi et al., 2009). The
mass of the rat V1aR is 44 kDa and comprises 394 amino acids.

In the rat brain,

autoradiography studies found prominent V1aR binding in olfactory bulb, hippocampus, lateral
septum, paraventricular nucleus, ventral tegmental area, raphe nuclei, locus coeruleus, nucleus of
the solitary tract, subfornical organ, area postrema and hypoglossal nucleus (Ostrowski et al.,
1994); (Ostrowski et al., 1992).

Arginine vasopressin through V1aR aids in the regulation of
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blood pressure through vascular contractions, arterial baroreceptor reflex, sympathetic nerve
activity, water reabsorption, lipid metabolism, protein catabolism and glucose tolerance
(Caldwell et al., 2008; Aoyagi et al., 2009)
Campbell et al., 2009 studied the V1aR pattern in two species of singing mice Scotinomys.
teguina and Scotinomys. xerampleinus.

The V1aR binding was evident in lateral septum,

centromedial and ventrolateral nuclei of thalamus, supraoptic nucleus, paraventricular nucleus,
amgydala and globus pallidus.

No significant binding was observed in hippocampus and

olfactory bulb. Receptor binding was higher in forebrain of S. teguina while thalamic regions
had higher binding with S. xerampelinus. There was fiber tract binding in S. xerampelinus that
was suggested to be V1aR expressed in glial cells or localization of V1aRs in neuronal axons.
The high receptor density was observed in periaqueductal gray and anterior hypothalamus
(preoptic area) in S.teguina. Periaqueductal gray is associated with vocal production in singing
mice while anterior hypothalamus is important for partner preference and association. Similarly,
strong binding was observed in the medial geniculate nucleus which is associated with auditory
function. Based on anatomical evidence, the V1aR plays a functional role in regulating speciesspecific vocal behavior (Campbell et al., 2009).
Tuco-Tuco is a rodent species found in South America. The V1aR distribution in two closely
related species of Tuco-Tuco, Ctenomys haigi and Ctenomys sociabilis were studied. The V1aR
binding was observed in the following neural structures: lateral septum, ventral pallidum,
nucleus accumbens, hippocampus, and arcuate nucleus of the hypothalamus (Beery et al., 2008).
The V1aR binding was evident in the brain of golden hamsters in the following structures:
cerebral cortex (cingulate, insular, retrosplenial, temporal and perirhinal cortex), corpus striatum,
lateral septum, amgydala, bed nucleus of stria terminalis, hippocampus, suprachiasmatic nucleus,
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medial preoptic nucleus, superior colliculus, area postrema, subfornical organ, nucleus of solitary
tract, hypoglossal nucleus, ventral tegmental area, raphe nuclei, paraventricular nucleus and
periventricular nucleus (Dubois-Dauphin et al., 1990). In hamsters, the V1aR plays a role in
flank marking behavior (Dubois-Dauphin et al., 1990) and aggression (Ferris, 2000). In anterior
hypothalamus, dense binding of the V1aR with vasopressin fibers was observed. The neurons
secreting vasopressin from the supraoptic nucleus and nucleus circularis reach the medial
preoptic nucleus of anterior hypothalamus and releas the peptide thereby aiding in aggression of
hamsters (Ferris, 2000)
The receptor subtype, V1aR was cloned in sheep with a similarity of 85% and 80% to human
V1a receptor and rat V1a receptor amino acid sequence, respectively. The gene encoding 418
amino acids has a Kozak consensus sequence (Kozak consensus sequence is a sequence of
mRNA that has the consensus [(gcc)gccRCCAUGG where AUG is a start codon] that helps in
translation. The receptor has two N terminal glycosylation sites, Asn 13 and Asn 26, seven
threonine and sixteen serine phosphorylation sites in the third loop of the transmembrane
domain. The receptor is expressed in brain, testis, aorta, pituitary, kidney, adrenal glands and
muscle (Hutchins et al., 1995).

1.4.2 VT1 receptor in amphibia:
In frogs, AVT increases mate calling frequency in males while phonotaxis in females.
Immunoreactive AVT cells are present in septum; amgydala pars lateralis, magnocellular
preoptic area, suprachiasmatic nucleus and hypothalamus (Boyd, 1997). The VT1R was widely
distributed in telencephalon, diencephalon and mesencephalon of the brain, though the
expression level varies from region to region. A high intensity signal was observed in nucleus
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ambens, ventral striatum, lateral pallium, preoptic nucleus and hypothalamic nucleus while a
moderate intensity signal was observed in amgydala and ventral thalamic nucleus (Acharjee et
al., 2004b; Acharjee et al., 2004a).
The V1a type receptor in newts is widespread in telencephalon, diencephalon, mesencephalon
and medulla oblongata.

The immunoreactive cells for the receptor were observed in the

following structures: mitral layer of the olfactory bulb, dorsal and medial pallium, lateral and
medial amgydala, bed nucleus of the decussation of the fasciculus telencephali, bed nucleus of
stria terminalis, anterior preoptic area, magnocellular preoptic nucleus, suprachiasmatic nucleus,
ventral thalamus, dorsal and ventral hypothalamic nucleus, tegmentum, interpeduncular nucleus,
median reticular formation and nucleus motorius tegmenti (Hasunuma et al., 2007; Hasunuma et
al., 2010).

1.4.3 V1a1 receptor in fish:
In fishes, AVT plays a key role in osmoregulation, seasonal biology and stress response.
Gills play a vital role in maintaining water and ion balance in homeostatic environment. This is
mediated through V1a receptors present in gills. Gills and renal tissues function together to
maintain body fluid homeostasis (Balment et al., 1993; Balment et al., 2006). The receptor
distribution of the V1aR

in the fish brain, Epinephelus adscensionis was observed in the

following structures: inner cell layer of the olfactory bulb, entopeduncular nucleus, lateral septal
organ, dorsal, intermediate and ventral nucleus of ventral telencephalon, supracommissural
nucleus, post commissural nucleus and lateral nucleus of ventral telencephalon, preoptic nucleus,
periventricular nucleus, tuberal nucleus, nuclei saccus vasculous, paraventricular organ,
preglomular nucleus, mammillary bodies, ventromedial thalamic nucleus, habenular nucleus,
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pretectal nucleus, purkinje cells in cerebellum, raphe nuclei and locus coeruleus. Arginine
vasotocin (AVT) can act as a neuromodulator or mediate its actions on monoamine
neurotransmitter systems through the V1aR. Based on its anatomical distribution it could also be
involved in olfaction, vision and learning (Kline et al., 2011)
A 2701 bp transcript produces the 384 amino acid polypeptide, vasotocin receptor (VTR)
in the Euryhaline flounder. The AVT receptor is homologous to the mammalian V1a receptor by
62%. The receptor is present in brain, kidney and gill of the flounder (Warne, 2001). The
receptor plays a key role in water loss in these fishes by increasing the secretion mechanisms of
AVT (Warne et al., 2005).

1.4.4 Functional role of V1a receptors:
The functional roles of V1aR in mice were elucidated to be: social recognition, anxiety, while
other tasks like memory and learning effects were more task oriented.

Emotionality, however

wasn’t affected by V1aR activation (Bielsky et al., 2004; Bielsky et al., 2005a). The lateral
septum via V1a receptors may play a key role in processing olfactory information received from
conspecifics and delivering it to hypothalamus and hippocampus (Bielsky et al., 2005b).

A

V1aR agonist (Terlipressin) helped in reduction of vascular leakage in hypotensive and sepsis
patients (Kampmeier et al., 2010). The receptor also helps in restoring the vasomotor tone and
urine output by regulating renal blood flow (Holmes et al., 2011). The receptor also induces
vasoconstriction in septic shock patients (Kampmeier et al., 2010). The receptor also regulates
the expression levels of clock controlled genes (Li et al., 2009). The V1aR helps to maintain net
water balance in brain through aquaporin channels present in cerebral cortex by water
reabsorption (Niermann et al., 2001). Under water deprived conditions, V1aR enhances
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locomotor activity by activating orexin neurons to locate the sources of water (Tsunematsu et al.,
2008; Ulrich-Lai and Herman, 2009). The V1aR targets might play a role in post traumatic brain
injury and secondary brain damage (Trabold et al., 2008). Arginine vasopressin (AVP) via
V1aR regulates maternal aggression, grooming and licking behavior and maternal behavior in
lactating rats (Nephew and Bridges, 2008). The gene AVPR1A encodes for AVP receptor
subtype V1aR. The variability of the 5’ flanking region of AVPR1A gene affects pair bonding
behavior and affiliation in humans (Walum et al., 2008). The prairie vole has two copies of the
AVPR1A gene while the montane vole has only one copy. Montane voles have microsatellite
elements (repetitive di- and tetra-nucleotide sequences) that aid in transcriptional regulation of
the V1aR. In prairie voles, there are short and long alleles of microsatellite elements, the long
alleles are correlated with high binding intensities in the lateral septum and olfactory bulb and
are associated with behavioral functions like grooming and licking (Nair and Young, 2006). The
receptor, V1aR exhibits enormous plasticity that contributes to species differences in voles.
(Winslow et al., 1993; Young et al., 1997; Young et al., 1999).
The growth locus QTL present in chromosome 1 in chickens has been under a strong
selection process in breeding strategy programs over the past several decades.

The QTL

(growth) region in chickens has 50 genes including AVPR1a. The AVPR1a gene encodes for the
neuroendocrine peptide AVT. This gene is associated with behavioral traits in humans and birds
(Goodson et al., 2004; Bielsky et al., 2005b; Walum et al., 2008). A microsatellite allele for
homozygosity was selected from the AVPR1a gene located in the growth QTL on chromosome 1
and evaluated to test if the genotype is responsible for social or explorative behavior. Several
behavioral tests including a complex environment test, sociality test, mirror test and resident
intruder test clearly shows that there is a marked difference in social and emotional behavior in
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chickens. The study concluded that there might be an impact on emotionality and sociality of
birds when the chicken is selected for growth and breast production during domestication (Wiren
and Jensen, 2011).

1.5 Chicken AVT receptors:
The neurohormone AVT effects are mediated through G protein coupled receptors (GPCR).
Chicken vasotocin gene is intermediate between the mammalian AVP gene and that of lower
vertebrates. Specifically the AVT gene has a C terminal that is not cleaved properly from the
neurophysin but glycosylated. The gene encoding vasotocin has a single copy with three exons
and two short intervening sequences (Hamann, et al., 1992). Arginine vasotocin receptors are
characteristic GPCRs having seven transmembrane domains, an extracellular N terminal,
carboxy C terminal and two to three glycosylation sites in the N terminal domain (Baeyens and
Cornett, 2006) . The heptahelical membrane proteins activate G proteins to perform effector
functions (Birnbaumer, 2000). Functions of vasotocin include osmoregulation, increase in water
permeability through AVT dependent aquaporin channels, regulation of blood pressure,
oviposition and release of ACTH in response to stress. In addition, it also plays a major role in
sexual behavior, social behavior, aggression and vocalization (Baeyens and Cornett, 2006). To
date four types of avian VT receptors are known: VT1, VT2, VT3 and VT4 receptors. The
receptors are compared to the human AVP receptors in Table 7.
Table 7: Homology of mammalian AVP receptors and chicken AVT receptors based on
percentage identity (%) of their respective amino acid sequences
Species

Human V1aR

Human V1bR

Human V2R

Human OTR

Chicken VT1R

48

49

46

43

Chicken VT2R

53

62

45

50
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Chicken VT3R

49

51

44

74

Chicken VT4R

69

53

43

51

1.5.1 VT1 receptor:
In chicken, the VT1 receptor was the first receptor identified in the vasotocin family and
comprised 370 amino acids. The receptor is present in brain and in shell gland (Tan et al., 2000).
The neuropeptide AVT via the VT1 receptor activates prostaglandin release in the shell gland
resulting in contraction of smooth muscles and facilitating egg parturition (Seth et al., 2004a;
Seth et al., 2004b). The receptor is also present in the endometrium in shell gland suggesting its
role in contraction of smooth muscles in the uterus for expulsion of the egg. This receptor helps
in AVT induced phosphatidylinositol turnover and high intracellular calcium mobilization. The
receptor, however, induces uterine contractions during laying cycle as a possible paracrine
mechanism. The receptor also has oxytocic-like activity that could play a role in maternal
behavior (Tan et al., 2000; Baeyens and Cornett, 2006).

1.5.2 VT2 receptor:
The second receptor subtype identified and cloned was the VT2 receptor comprising 425
amino acids. The VT2R was predominant in the anterior pituitary, however, absent in brain
(Cornett et al., 2003; Jurkevich et al., 2005; Baeyens and Cornett, 2006; Jurkevich et al., 2008).
The VT2R is widely expressed in the cephalic lobe and scarcely distributed in caudal lobe of
anterior pituitary. The receptor VT2R was colocalized with a high percentage of corticotropes
followed by a smaller proportion of lactotropes.

The main function of the receptor, based

largely on its anatomical distribution and molecular interactions is the neuroendocrine regulation
of stress responses and in the release of ACTH and corticosterone (Cornett et al., 2003;
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Jurkevich et al., 2005; Baeyens and Cornett, 2006; Mikhailova et al., 2007; Jurkevich et al.,
2008; Kuenzel and Jurkevich, 2010).

1.5.3 VT3 receptor:
The third receptor identified and cloned was the VT3R. It is 391 amino acids in length and
expressed in the endometrium and myometrium of the shell gland. It suggests that this receptor
might be involved in oviposition (Gubrij et al., 2005).

1.5.4 VT4 receptor:
The AVP vascular receptor responsible for blood pressure regulation is the V1a vasopressin
receptor in mammals. The V1aR is activated through phospatidyinositol and intracellular
calcium signalling pathway. It also activates phospholipases A2, C and D (Peter et al., 1995).
Recently, the VT4 gene was sequenced and submitted to GenBank (Cornett, 2007, Genebank
submission). The receptor VT4R comprises 419 amino acids and has two exons and one intron.
The VT4R shares 69% similarity with V1aR of mammals (Baeyens and Cornett, 2006).

The

VT4 receptor is a novel receptor identified in chickens with little information available. The
present study was designed to determine the VT4 receptor distribution in brain and pituitary
gland of chickens.

1.6 Summary:
Avian vasotocin receptors, largely by amino acid sequence identity, have been shown to be
comparable to mammalian vasopressin receptors. The VT4R of chickens shares the highest
sequence homology with the mammalian V1aR. Most of the studies have focussed on the V1a
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receptor brain distribution and its association with social behavior in mammals. The current
study focuses on the receptor distribution in the avian brain and anterior pituitary gland.
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Abstract
The neurohormone arginine vasotocin (AVT) in non-mammalian vertebrates is homologous
to arginine vasopressin (AVP) in mammals. Its actions are exerted via G protein coupled
receptors that belong to the vasotocin/mestocin family. Arginine vasotocin mediates some of its
effects through receptors located in anterior pituitary cells. Recently, an avian vasotocin receptor
subtype designated VT4R has been cloned which shares 69% sequence homology with a
mammalian vasopressin receptor, the V1aR. In the present study, a polyclonal antibody to
VT4R was developed and validated to confirm its specificity. The antibody was used to test the
hypothesis that the VT4R has a regional distribution and found on specific types of cells in the
avian anterior pituitary. Western blotting of membrane protein extracts from pituitary tissues,
use of HeLa cells transfected with the VT4R and peptide competition assays have confirmed the
specificity of the antibody to the VT4R. Dual labelled immunofluorescence microscopy was
utilised to identify pituitary cell types that contained immunoreactive VT4Rs. The receptor was
found widely distributed throughout the cephalic lobe of the anterior pituitary demonstrating its
regional distribution.

Immunoreactive VT4Rs were associated with both corticotrophs and

gonadotrophs. Approximately 89% and 12% of immunolabelled corticotrophs and gonadotrophs
were shown to be immunoreactive for the VT4R, respectively.

In both corticotrophs and

gonadotrophs, the colocalisation of cells was present in the cephalic lobe of the pituitary. No
immunoreactive VT4Rs were found in somatotrophs or lactotrophs. The high percentage of
corticotrophs colocalised with the VT4R suggests a role of the receptor in stress responses.
Keywords: V1aR, stress, cephalic lobe, corticotrophs, gonadotrophs.
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1. Introduction:
Homeostatic imbalance leads to activation of the hypothalamic pituitary adrenal axis (HPA)
by secreting neuropeptides arginine vasopressin (AVP) and corticotropin releasing hormone
(CRH). The neuropeptides are produced in the hypothalamus and transported to the anterior
pituitary resulting in secretion of adrenocorticotrophic hormone (ACTH) from cotricotrophs.
The ACTH acts on the adrenal cortex to stimulate release of glucocorticoids in humans. In avian
species, ACTH stimulates the release and production of corticosterone in adrenal chromaffin
tissues (1-6). Chicken CRH is identical to CRH of humans and rats (7, 8). Arginine vasotocin
(AVT) is the non-mammalian counterpart of arginine vasopressin (AVP). Avian AVT differs
from mammalian AVP in position 3 of the amino acid sequence (phenylalanine to isoleucine
substitution in birds). Similar to mammals, avian ACTH contains 39 amino acids. Avian ACTH
differs from human ACTH in 8 different positions of the amino acid sequence (positions 15, 20,
27, 28, 29, 30, 31 and 33) (9, 10). There have been several studies in birds on CRH (8, 11-13)
and AVT (12-17) emphasizing that both CRH and AVT aid in the regulation of stress reponses
by acting synergistically to release ACTH (3, 12, 18-25). The release of ACTH was observed in
rats when AVP was microinjected into third ventricle of freely moving rats. Rats subjected to
ether stress (acute stress) also showed an increase in ACTH release (26) Arginine vasopressin
mediated the release of ACTH in a dose-dependent manner from rat anterior pituitary cells in
vitro (23, 26, 27). Plasma LH levels increased in response to ether stress in female rats.
Nevertheless, injection of AVP antiserum into ether stressed rats resulted in a decline in plasma
LH levels (26). Arginine vasopressin stimulated the release of LH from gonadotrophs in rats
(28), perfused rat pituitary cells (28, 29) and in cultured hemipituitaries of rats (30), however,
intracerebroventricular administration of AVP lowered the level of plasma LH release in male
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rats (21). In hamsters, AVP stimulated the release of LH and prolactin from anterior pituitary
cell cultures in a dose dependent manner (31). Arginine vasopressin/AVT mediated the release
of prolactin in cultured hemipituitaries in vitro (30). An intravenous and subcutaneous injection
of AVT/AVP caused an increase in prolactin levels in rats pretreated with estradiol benzoate and
progesterone (32, 33). Intracereboventricular injection of AVT increased plasma CORT levels
but the response was significantly less than CRF induced plasma CORT levels in chicks (12, 13,
34). The neuropeptides, AVT and CRF at equal concentrations potentiated the release of ACTH
from dispersed perfused duck pituitary cells (19, 20). Prolactin secretion was stimulated by AVT
in monolayer cultures of turkey anterior pituitary cells (35) and in adult male chickens (36).
Arginine vasopressin/AVT act through G protein coupled receptors to mediate their effector
functions.

In mammals, the AVP/oxytocin (OT) family of receptors comprises four major

subtypes: vasopressin (V) V1a, V1b, V2 and OT receptors. In birds, four receptor subtypes in
the vasotocin family have been identified VT1R, VT2R, VT3R and VT4R. The first identified
vasotocin receptor, VT1R comprised 370 amino acids. The receptor is present in the shell gland
and brain of chickens (37, 38). It appears to be a homolog of the V2 receptor in humans. The
VT1 receptor shows only 46% identity with its mammalian homolog and 51% identity with other
VT receptor suggests that its an early divergent receptor from the other avian receptors. The
receptor plays a role in contraction of smooth muscles in the uterus during oviposition (38). The
VT2R is a 425 amino acid protein found predominantly in the cephalic lobe of the avian anterior
pituitary but absent in brain. The VT2R is the non- mammalian homolog of V1b receptor (39,
40). The receptor plays a role in mediating the secretion of ACTH from corticotrophs and to a
lesser extent prolactin (PRL) from lactotrophs based upon co-localization of the VT2R in
corticotrophs and lactotrophs, respectively (36, 37, 39, 40). In several mammalian species
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including rats (41), mice (42, 43) and humans (44), the V1bR is the most abundant receptor in
pituitary. The major role of the receptor is to facilitate the release of ACTH from the anterior
pituitary during stress responses in both mammals and non-mammalian species (36, 40-42, 45).
The third cloned receptor, VT3R is a 391 amino acid protein. The receptor is present in the
myometrium and endometrium of the shell gland in chickens (37, 46). The non-mammalian
counterpart of the oxytocin receptor is suggested to be the VT3R in chickens (46). The receptor
might play a role in oviposition by stimulating myometrial contractions in uterus (46).
The VT4R in chickens is the non-mammalian counterpart of the V1aR in mammals. The
VT4R is a novel vasotocin receptor that has been cloned recently in chickens (Cornett, 2007,
GenBank Accession no: XM_001235007). The receptor comprises 419 amino acids and its gene
(AVPR1A) is present in chromosome 1(47).

The VT4R shares an amino acid sequence

homology of 69% when compared to the V1aR in humans (37). The receptor has been suggested
to play a role in the regulation of blood pressure (37). Several studies have been done on the
V1aR in humans (44), rats (28, 42, 43, 48), mouse (49, 50), frogs (51, 52) and newts (53, 54). In
rats, V1aR is present in the anterior pituitary and colocalises with gonadotrophs (28, 42, 43) . A
definitive distribution of VT4R in anterior pituitary has not yet been reported in chicken. The
avian VT4R has the highest sequence homology to the mammalian V1a receptor (69%)
compared to the other three receptors (VT1R (48%), VT2R (53%) and VT3R (49%) (See Table 1
for references). Since the vasotocin system in avian species is involved with the regulation of
stress (13, 36, 40, 55), a study was designed to determine whether or not the VT4R occurs in the
anterior pituitary of the chicken. The hypothesis tested was that the VT4R is expressed in avian
anterior pituitary cells.
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2. Materials and methods
2.1 Animals
(a) Organs sampled for antibody validation study: Twenty anterior pituitary glands were
obtained from 6-8 week old birds for the extraction of membrane protein. Birds were cervically
dislocated and heads placed on ice. The pituitary glands were immediately dissected, frozen on
dry ice and stored in Eppendorf vials at -80°C.

(b) Animals utilized for immunohistochemical study: Six adult male broiler birds (24-32
weeks old) were utilised for the study of the VT4R distribution in anterior pituitary. All birds
used in the current study were kept individually in cages under a 14h light and 10h dark lighting
cycle. Food and water were given ad libitium. All animals used in this study were treated in
accordance with the protocols approved by the University of Arkansas Institutional Animal Care
and Use Committee.

2.2 Antibody production for vasotocin receptor subtype 4 (VT4R)
Polyclonal antibodies to the chicken vasotocin receptor VT4R were raised in rabbit against
synthetic peptides. In brief, rabbits were injected with two peptides, one peptide comprising 15
amino acids from the amino terminal region, AGDWDPFGRDEELAC (residues 45-58) and
other

peptide

containing

17

amino

acids

from

the

carboxy

terminal

region,

NSNSRRQTSFTNNRSPT (residues 376-392) of the chicken VT4 receptor (Cornett, 2007,
GenBank submission). The two peptide sequences selected were unique between VT4 and other
vasotocin receptor subtypes (GenBank Accession No: XM_001235007). For ease of conjugation
of the peptides to a carrier, a cysteine thiol with a 6 carbon spacer and glutaraldehyde was added
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to the C terminal and N terminal, respectively. The peptides were then conjugated to a carrier
protein, keyhole limpet Hemocyanin (KLH) by the use of bifunctional reagent mmaleimidobenzoyl N hydroxy succinimide (MBS). The conjugate was used to immunize two
rabbits with a booster dose given at 2 week intervals. The bleeds were collected at 52, 56, 73
and 80 days. The antiserum from rabbit 1 obtained at 73 days (bleed 3) gave the best staining
pattern in pituitary sections using immunohistochemistry. This antiserum named as VT4#3/63
was subsequently used for future studies. The antibody was developed by 21 st Century
Biochemicals Inc. (Marlboro, MA).

2.3 Tissue and VT4R cell lysates
Membrane protein fractions from pituitary glands were extracted using a plasma membrane
protein extraction kit (Biovision, CA, USA) as per the manufacturer’s protocol. Tissues were
homogenised with the buffer mix provided and the cellular membrane protein fraction was
obtained by centrifugation at 10, 000g for 30min. The pellet was resuspended in equal volumes
of upper phase and lower phase buffers provided in the kit. After repeated centrifugations, the
plasma membrane protein fraction lysate was obtained. The concentration of the protein lysate
was estimated by RC/DC (reducing agent and detergent compatible) protein assay kit II (Biorad,
CA, USA).
HeLa cells were seeded onto 10 cm dishes in 10 ml growth medium (10% fetal bovine serum
and Eagle`s minimum essential medium) and incubated in a 5% CO 2 incubator. Twenty hours
post transfection; the cells were transiently transfected with 2.8µg of cDNA encoding VT4R
with expression vector pcDNA3 or 2.8 µg of pGEM7-Z in 50 µl of OPTI-MEM (Gibco,
Invitrogen, USA) using Lipofectamine 2000 method (56). The cells were incubated at 37°C in a
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5% CO2 incubator for 4 hours. The transfection medium was removed and replaced with fresh
medium (39).

Ten days after post-transfection, cells were scrapped from the dishes and

resuspended in PBS and the cell count was estimated. Later, the cells were centrifuged at 14,000
rpm for 15 min. The pellets were resuspended in 15 ml of PBS. The cells were aliquoted into
smaller volumes and centrifuged at 14,000 rpm for 15min. The supernatant was aspirated,
washed with PBS and frozen with liquid nitrogen. The HeLa cell aliquots transfected with the
VT4R were prepared by Sandie Jacoby, University of Arkansas for Medical Sciences and
shipped to our laboratory.

2.4 Western blotting:
Fifty micrograms of protein from pituitary tissue lysate and 40 µg of VT4R cell lysate were
diluted in 6X concentrated Laemmli buffer containing sodium dodecyl sulphate (SDS) and βmercaptoethanol.

Samples were heated for 15 min at 90°C and loaded on 12% SDS

polyacrylamide gel and the proteins were separated at 180V for 55 min (BioRad, CA, USA).
Proteins were transferred to a nitrocellulose membrane at 0.25A for 70 min (BioRad, CA, USA)
using Tris-Glycine HCl buffer pH 9.5. The membrane was immersed in 5% non-fat milk
(Sigma, St. Louis, MO, USA) for 30 min to block non-specific binding sites. The membrane
was incubated overnight with primary rabbit antiserum against chicken VT4R at a working
dilution of 1:1200, rinsed in Tris-buffered saline with 1% Triton-X 100 (TBS-T) and incubated
with horseradish peroxidase-conjugated goat anti-rabbit IgG for 1 hr (Santa Cruz Biotechnology,
CA, USA). The membrane was washed with TBS-T. An Enhanced Chemiluminescence Kit
(Amersham Biosciences, NJ, USA) was utilised to visualise the immunoreactive bands on Kodak
Biomax Maximum Resolution Autoradiography film (Carestream Health, PA, USA).
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Specificity of the antibody was tested using a peptide competition assay or preadsorption
assay with the protein fraction obtained from pituitary tissues. The antibody at a working dilution
of 1:1200 was preincubated with increasing amounts of the antigenic peptides (5µg and 50 µg)
for 3 hours at room temperature. The peptide-antibody complex was centrifuged at 12,000 rpm
for 30 minutes at room temperature. The supernatant was used as a substitute for the primary
diluted antiserum normally used in the Western blot.

2.5 Immunohistochemistry
2.5.1 Sample preparation
Birds were anaesthetised with an intravenous injection of sodium pentobarbital (40 mg/kg i.v)
and perfused through cartoid arteries with 250 ml heparinized phosphate buffered saline (0.1M
PBS with 0.1% sodium nitrite, pH 7.4) immediately followed by fixation using 400 ml of
Zamboni`s fixative (4% paraformaldehyde with 15% saturated picric acid in 0.1M PBS buffer
pH 7.4). The pituitary glands were dissected from the cranium, postfixed in the same fixative
overnight at 4°C, cryoprotected in 30% sucrose in 0.1M PB at 4°C until they sank to the bottom
and subsequently frozen in dry ice and stored until sectioned.

The pituitary tissues were

embedded in Jung OCT medium to form a tissue block (Leica Microsystems, Germany) and
sectioned at 10 µm in horizontal/coronal planes on a cryostat (Leica CM 3050S, Leica
Microsystems, TX). Sections were collected on double coated gelatinized microscopic glass
slides and stored at -80°C in sealed boxes with dessicant

until processed for

immunohistochemistry.
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2.5.2 Bright field immunohistochemistry
Slide-mounted sections were rinsed in PBS to remove fixative. Endogenous peroxidase
activity was suppressed using 0.6% hydrogen peroxide followed by cell permeabilization with
0.4% Triton X-100. Sections were placed in 5% normal goat serum (NGS) for 30 min to block
non-specific binding sites. Sections were incubated in primary rabbit antiserum against VT4R
for 40hrs (dilution 1:3000 in 0.02M PBS with 1% NGS, 0.2% Triton X-100). Sections were
incubated with goat anti rabbit IgG (Vector Laboratories, CA, USA) for 90 min followed by
Vectastain Elite ABC peroxidase complex incubation for 90 min (dilution 1:5, Vector
Laboratories, CA, USA).

Immunoreactive VT4R cells were visualized using chromogenic

diaminobenzidine nickel complex developed in the presence of glucose oxidase (57). After
several rinses of PBS, sections were coverslipped with Histamount (National Diagnostics, CA).

2.5.3 Immunofluorescence
Slide mounted pituitary sections and fixed cultured HeLa cells transfected with the VT4R
gene were subjected to immunofluorescence. Sections were rinsed in PBS to remove fixative;
cell permeabilization was done using 0.4% Triton X-100 for 20 min. Sections were covered with
10% normal donkey serum (NDS) in TBS (PBS with added 0.2% Triton X-100, pH 7.4) for
30min (Jackson Immunoresearch, PA) to decrease non-specific immunostaining. Later, they
were incubated with rabbit antibody against chicken VT4R diluted 1:2000 (in TBS with 1%
NDS) for 40 hrs at 4°C. Sections were washed in three changes of PBS followed by incubation
with Texas Red donkey anti-rabbit IgG or DyLight 594 donkey anti-rabbit IgG for 90 min at
room temperature in a humidified chamber (dilution 1:500 in TBS, Jackson Immunoresearch,
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PA). After three changes of PBS, sections were coverslipped with Vectashield or Vectashield
with DAPI to counterstain cell nuclei (Vector Laboratories, CA).

2.5.4 Dual labelling immunofluorescence:
The types of pituitary cells immunoreactive for VT4R were determined using a dual labelling
immunofluorescence study. This study focussed on the presence of VT4R immunoreactivity in
pituitary corticotrophs, gonadotrophs, somatotrophs and lactotrophs.

Sections were washed,

permeabilized and blocked as described in section 2.5.3. Sections were then incubated with a
cocktail of rabbit antiserum raised against chicken VT4R (VT4 #3/63) and mouse monoclonal
antibody to chicken proopiomelanocortin, prolactin (PRL), luteinising hormone (LH) or growth
hormone (GH). All primary antibodies, source and dilutions that were employed in this study
are listed in Table 2. Sections were incubated with either of the above cocktail for 40-45 hrs at
4°C (1% NDS, 0.2% Triton X-100 in PBS). It was followed by three rinses in PBS 10 min each
and incubation with a cocktail of Texas Red donkey anti-rabbit IgG and DyLight 488 donkey
anti-mouse IgG diluted at 1:500 (PBS with 0.2% Triton X-100) for 90 min at room temperature
in a humidified chamber. All secondary antibodies used in this study were obtained from
Jackson Immunoresearch, PA. The antibodies were of multiple labelling grades that were solid
phase adsorbed to reduce cross reactivitiy to IgG of other species. Immunolabelled sections
were coverslipped with Vectashield or counterstained by Vectashield with DAPI (Vector
Laboratories, CA USA).
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2.6 HeLa cell transfection with chicken VT4R gene using Lipofectamine:
To validate that the antibody is specific to VT4R in cells, immunocytochemistry was
performed on HeLa cells containing the vector pcDNA3-VT4 and pcDNA3-VT1, pcDNA3-VT2,
pcDNA3-VT3 respectively. In brief, the HeLa cells were seeded onto a four-chamber slide (Lab
Tek-II Chamber Slide system, Rochester, NY) at a concentration of 2X10 5 cells per chamber in 1
ml growth medium. The growth medium contains 10% fetal bovine serum and Eagle`s esssential
minimum medium in the absence of antibiotics.

Twenty four hours later, the cells were

transiently transfected with 2.8 µg of expression vector pcDNA3 containing cVT4R, cVT1R,
cVT2R or cVT3R in 1 µl of Lipofectamine 2000 (Invitrogen, CA, USA) in 50 µl OptiMEM
(Gibco, Invitrogen, CA, USA) per chamber. Cells were incubated in a 5% CO 2 incubator. In
addition, pCDNA3 containing cVT2R was tagged with Yellow Fluorescent Protein (YFP). Two
chambers of HeLa cells were left nontransfected to serve as negative controls with each subtype.
The transfection efficiency of cells was about 75-80%. Forty eight hours later, the slides were
rinsed with PBS pH 7.4, fixed with 4% paraformaldehyde in 0.1M PBS, pH 7.4 for 15min at
room temperature, briefly rinsed again with PBS, dried overnight at 4°C and freezed at -80°C in
sealed slide boxes. The slides were processed for immunocytochemistry as described in section
2.5.3 as a confirmatory test for antiserum specificity. The cell nuclei were counterstained using
DAPI.

2.7 Antiserum specificity tests:
The peptide used as an antigen was preadsorbed with the antibody produced as a specificity
control. Antiserum in a working dilution 1:1200 was preincubated with 8 µg and 50 µg of the
peptide for 3 hrs at room temperature and centrifuged for 30 min at 14,000 rpm. The supernatant
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obtained was substituted for

primary antiserum on brain sections processed

immunofluorescence labelling as described in section 2.5.3.

for

Additional controls included

omission of primary or secondary antibody from all immunocytochemical protocols described
above. Additionally, in dual labelling protocols, the specificity tests included the omission of one
of the primary or one of the secondary antibodies.

2.8 Image Analysis
Sections were examined using an Axioplan Fluorescence Research Microscope (Carl Zeiss,
USA).

Images were captured using a Nikon Eclipse 90i upright scanning laser confocal

microscope (Nikon systems, USA). The image adjustments for confocal images were controlled
by Fiji software version 1.45r. The brightness and contrast were adjusted in Adobe Photoshop
CS5.
The proportion of corticotrophs and gonadotrophs colabelled for the VT4R was quantified
using three animals. Two sections (per animal) sectioned near the middle of the cephalic lobe
were chosen for analysis.

Each histological section was scanned using epifluorescence

illumination at 40x magnification, switching between GFP and Rhodamine filters. Based on
random sampling, six regions were imaged in each section using Axiovision product suite 4.0.6
(Carl Zeiss, USA). The cells were counted within six 165µm X 165µm fields per section per
animal. Corticotroph or gonadtroph immunoreactive cells were counted in each region provided,
and cells single labelled and colabelled for the VT4R were tabulated. All data were recorded as
means ± one standard deviation. The proportion of dual labelled corticotrophs and gonadotrophs
were calculated.
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3. Results
3.1 Antiserum specificity:
(a) Western blot:
The specificity of the rabbit VT4R #3/63 antiserum was tested using the Western blot
procedure and membrane protein extracts of chicken pituitary tissues. The antibody revealed a
robust single band at 46-47KDa with pituitary tissue and HeLa cells transfected with an
expression vector encoding chicken VT4R cDNA. The absence of the 46-47KDa band was
observed in Hela cells transfected with an expression vector pGEM7Z lacking the VT4R (Fig
2A). Preadsorption of the antibody with 5µg of immunogenic peptides attenuated the intensity
of the band while the staining was completely abolished by the antiserum preadsorbed with 50
µg of immunogenic peptides (Fig 2B).

(b) Immunocytochemistry:
In coronal sections of pituitary, VT4R immunoreactive receptors were observed in the
cephalic lobe of the anterior pituitary (Fig 3A). The preadsorption of antibody with 8 µg of
peptide significantly reduced the immunostaining of cells while absence of VT4R
immunoreactivity was observed with 50 µg of peptide preadsorbed with the antibody (Fig 3B
and 3C).
HeLa cells transfected with VT receptors were used as a final test to validate the specificity of
the antibody. Rabbit VT4R #3/63 antibody revealed immunoreactivity in cultured HeLa cells
transfected with an expression vector encoding chicken VT4R cDNA. Almost all cells had
immunoreactivity displayed throughout the whole cell profile (Fig 4A and 4B) while few cells
had VT4Rs internalized (Fig 4B). Absence of VT4R immunoreactivity was observed in HeLa
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cells transfected with plasmid pGEM7Z lacking VT4R (Fig 4C), expression vector encoding
chicken VT1R cDNA (Fig 4D), VT2R cDNA (Fig 4E) and VT3R cDNA (Fig 4F).

3.2 Regional distribution of VT4R in anterior pituitary:
The vasotocin receptor, VT4R immunoreactive cells were present predominantly in the
cephalic lobe of the anterior pituitary gland, although a few cells were scattered in the caudal
lobe of anterior pituitary (Fig 5, 5A and 5B). The VT4R immunoreactive receptor was arranged
either as a group of cells clustered together (Fig 5A, 5B and 5C) or scattered individual cells (Fig
5A, 5C, 6D).

Immunolabelled VT4Rs were round or oval in shape (Fig 5C, 6C and 6D) and

were associated with plasma membrane and more prominently in the cytoplasm (Fig 5B, 5C,
6C).

3.3 VT4R in corticotrophs:
Dual immunofluorescence labelling for the VT4R and POMC revealed that a large population
of corticotrophs contained immunoreactive VT4Rs. These cells were shown distributed either as
a group of 8-10 cells or as scattered, individual cells observed strictly in the cephalic lobe of
anterior pituitary.

Pro-opiomelanocortin (POMC) cells containing VT4Rs occurred at the

periphery and in the cytoplasm of each cell (Fig 7A, 7B and 7C). The proportion of POMC cells
containing VT4R varied from 88% to 91% with a mean of 89.2%. The proportion of VT4Rs
containing POMC varied from 70% to 74% with a mean of 72%.
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3.4 VT4R in gonadotrophs labelled for luteinising hormone (LH):
Gonadotrophs containing LH were present throughout the cephalic and caudal lobes in the
avian anterior pituitary. Dual labelling of the VT4R and LH revealed a minor population of
gonadotrophs immunoreactive for the VT4R.

Colocalised cells were observed only in the

cephalic lobe of the anterior pituitary. Colocalisation of the VT4R in LH immunoreactive cells
was shown mostly in the peripheral regions of the cells (Fig 7D, 7E and 7F). The percentage of
LH cells containing VT4R ranged from 11% to 13% with an average of 12%.The proportion of
VT4Rs containing LH ranged from 15 to 17% with an average of 16.2%.

3.5 VT4R in lactotrophs/somatotrophs:
Dual labelling of VT4R was completed with somatotrophs and lactotrophs.

Neither

lactotrophs nor somatotrophs had immunoreactive VT4R in their cells. Lactotrophs and VT4R
are both present in the cephalic lobe of anterior pituitary.

Nevertheless, there were no

immunolabelled cells that contain both VT4R and lactotrophs (Fig 8).
With regard to somatotrophs, there was a difference in regional distribution of the receptor
and hormone in the anterior pituitary. Somatotrophs are present in the caudal lobe of pituitary
while the receptor is present in cephalic lobe. Examination of the region around the anatomical
boundary of the two lobes wherein the distribution overlapped did not have any somatotrophs
containing the VT4R (Fig 9).
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4. Discussion
4.1 Antiserum specificity:
In order to investigate the distribution of the VT4R in the pituitary gland, a polyclonal
antibody was raised in rabbit against a cocktail of two peptides. The specificity of the VT4R
#3/63 antibody was evaluated by four major techniques: Western blot using pituitary tissues,
Western blots on transfected cells, immunohistochemisty, peptide competition or preadsorption
assays with Western blots and with immunohistochemistry (58-60). The receptor protein VT4R
was detected from membrane protein extracts at 47 KDa utilising a Western blot. The predicted
size of the receptor based upon its molecular weight of 419 amino acids encoding the receptor is
46.2 KDa which is in good agreement with the estimated mass of the band. The absence of a
band at 47 KDa in non transfected HeLa cells and its disappearance when the VT4 #3/63
antiserum was preadsorbed with the cocktail of synthetic peptides against which the antibody
was raised lends support that the antibody specifically recognizes only the VT4R (Fig. 2).
As the primary goal of the antibody was to be employed in immunocytochemistry, the
antibody was tested for its specificity with sections of pituitary and cell cultures. The antibody
revealed immunoreactive cells in the cephalic lobe while the immunoreactivity was absent when
preadsorbed with a cocktail of peptides (Fig 3). In addition, HeLa cells transfected with the
VT4R had immunoreactive receptors present in the cytoplasm including its peripheral regions
and the absence of immunolabelled cells in cultures transfected with other VT receptors subtypes
(VT1R, VT2R, VT3R) (Fig 4). Results confirmed specificity of the antibody to the VT4R
protein.
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4.2 Anatomical distribution of VT4R in pituitary
Similar to mammals, the avian pituitary gland comprises an anterior and posterior pituitary.
The organization of anterior pituitary, however, is different from mammals. As suggested by
Wingstrand (1951) the anterior pituitary is subdivided into cephalic and caudal lobes (61). Two
separate sets of portal capillaries serving the anterior and posterior regions of the anterior
pituitary suggested the possible separation of functional groups of pituitary cells in the cephalic
and caudal lobes of anterior pituitary, respectively, of the white-crowned sparrow, Zonotrichia
leucophrys gambelii (62). The division of the anterior pituitary into two lobes has been
confirmed in other avian species (63, 64). The VT4R shown to be distributed regionally;
predominantly in the cephalic lobe (Fig 6A and 6B) provides further evidence for a functional
division of the avian anterior pituitary as well as our past data addressing the distribution of the
VT2R (36,40).

Most of the cells in cephalic lobe were labelled for the VT4R.

Present data

showing the great abundance of the VT4R in the cephalic lobe, the major lobe of the avian
anterior pituitary, as well as previously demonstrated abundance of the VT2R in the cephalic
lobe (36, 40) are in good agreement with high expression of VT2Rs and VT4Rs mRNAs (Kang
and Kuenzel, unpublished data) and suggest that the these receptors are likely the most abundant
vasotocin receptors present in the avian pituitary gland.

4.3 VT4R in corticotrophs/melanotropes:
The present study provides strong evidence that in male chickens, the VT4R are colocalised
with corticotrophs and gonadotrophs. Virtually 89.2% of cells that contained POMC were
labelled for VT4R. Anatomical results support previous studies that AVT stimulates the release
of ACTH (12, 34, 36). The receptor, VT4R is also present in neurons of supraoptic nuclei
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(SON), paraventricular nucleus (PVN) and internal (iz) and external zones (ez) of median
eminence (ME) (65). The VT4R located in hypothalamic neural structures associated with stress
(65) and colocalised with corticotrophs in the anterior pituitary, suggests that the VT4R is
involved in neuroendocrine regulation of stress responses.

The VT2R in chickens is also

colocalised in a high percentage of corticotrophs (36, 40) suggesting an interaction of both the
VT2R and VT4R in the stress response.
Proopiomelanocortin (POMC) is a big precursor protein that produces hormones including
ACTH and α-MSH by cleavage of prohormone molecules (66, 67). It has been shown that αMSH and ACTH are colocalised in same cells in anterior pituitary in chickens as well as possess
the VT2R (36). Similarly, the corticotrophs that contain the VT4R likewise contain α- MSH
suggesting that the VT4R not only mediates the release of ACTH but also α-MSH (36, 40).

4.4 VT4R in gonadotrophs:
Gonadotrophin releasing hormone type one (GnRH-1) is the primary neurohormone for the
release of gonadotropins from the anterior pituitary (68-70). There has been evidence suggesting
that AVP mediates the release of LH in mammals. In rats, AVP stimulates the release of LH and
FSH hormones (26, 28). Administration of AVP/AVT subcutaneously (71) causes a reduction in
the plasma levels and release of LH in rats (21, 71).

Administration of AVP

intracerebroventricularly lowered the plasma levels of LH release (21) while ether stressed
animals showed a concomitant increase in the plasma levels of LH release in adult rats (26).
Arginine vasopressin augments the release of LH in hamsters in a dose dependent manner in
vitro (31). In rats, almost all V1aR labelled cells were gonadotropes suggesting that V1aR
stimulates the release of LH (28). The presence of V1aR on gonadotropes implies that a direct
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action of AVP on these cells is plausible (28).

Certainly, AVT/AVP exerts various and

controversial actions on gonadotropes according to species, mode of administration and
neurotransmitter molecules (72, 73). In the present study, 12% of cells contain both VT4R and
LH immunoreactive cells. It would be of interest to determine whether the VT4R on
gonadotrophs function to stimulate or inhibit the release of LH from those cells.

4.5 VT4R in lactotrophs/somatotrophs:
In the present study, we have not found immunoreactive VT4Rs located either in lactotrophs
nor somatotrophs. Immunohistochemical results presented here suggest that AVT do not mediate
growth hormone or prolactin release via VT4R in chickens. Previous anatomical studies suggest
that the VT2R may regulate the release of prolactin from lactotrophs in birds (36). Arginine
vasopressin, mediates the release of prolactin in vivo and in vitro in rats (30, 32, 33) and in
hamsters (31).

4.6 Similarities between mammalian V1aR and avian VT4R:
The vasotocin receptor, VT4R shares 69% sequence homology with mammalian V1aR (Table
1). This receptor (VT4R) has the highest sequence homology with its mammalian counterpart
(V1a) compared to other vasotocin receptors. In chickens, VT2R and VT4R are most abundant
receptors of the vasotocin family of receptors in the anterior pituitary. In agreement with these
findings, V1bR and V1aR in mammals are the most abundant receptors in pituitary (28, 43). In
chicken, 89% of corticotrophs and 12% of LH containing gonadotrophs contain the VT4R. In
rats, the V1a receptor is found in 100 % of gonadotrophs (28) and is not found in corticotrophs
(28).
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In mammals, the V1a receptor is found in the neural structures of the brain including
paraventricular nucleus, hippocampus, median eminence, area postredema and subfornical organ
(42, 43). Behaviorally, the V1aR mediates effects of AVP on social recognition and pair bonding
(74, 75, 76-78), regulates maternal aggression, grooming and licking behavior and maternal
behavior in lactating rats (79). The role of V1aR in stress responses and reproduction are under
studied. Similarly, the VT4R is present in telencenphalon, diencephalon and mesencephalon of
brain and preliminary data suggest its involvement in stress pathways due to its distribution in
the supraoptic nuclei (SON), paraventricular nucleus (PVN) and median eminence (ME) (65).
Very limited information is available on the functional role of VT4R in stress responses and
social/reproductive behavior. Based on similarities in sequence homology, distribution in
anterior pituitary gland and brain, the VT4R proposes to be the avian homolog of the mammalian
V1a receptor subtype.

5. Concluding remarks
This study investigated the presence of VT4R in anterior pituitary. The VT4R was
predominantly present in the cephalic lobe of the anterior pituitary gland in chicken. The VT4R
was shown to be present in corticotrophs and gonadotrophs (LH containing cells) and not found
in somatotrophs or lactotrophs. The overall profile of VT4R in anterior pituitary gland and high
percentage of corticotrophs containing the VT4R suggest its involvement in the regulation of
stress. The VT4R also appears to play a role in the regulation of LH.
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List of tables:
Table 1: Amino acid identity (%) of chicken VT4R compared with mammals and other
members of vasotocin/oxytocin, vasotocin/mesotocin-isotocin receptor family to human
vasopressin V1a receptor (V1aR)
Receptor

Accession No.

Species

Identity (%)

Vasopressin V1a

U19906

Homo sapiens (human)

100

Vasopressin V1a

Z11690

Rattus norvegicus (rat)

80

Vasopressin V1a

D49730

Mus musculus (mice)

82

Vasopressin V1a

L41502

Ovis aries (sheep)

82

Vasopressin V1a

GU954352

Microtus montanus (Meadow vole)

83

Vasopressin V1a

AF069304.2

Microtus ochrogaster (Priarie vole)

82

Vasotocin VT4

EU124684.1

Gallus gallus (chicken)

69

Vasotocin V1a

XP 002187321

Taeniopygia guttata (Zebra finch)

66

Vasotocin VT

AY277924.1

Rana catesbeiana (Bull frog)

68

Vasotocin V1a

GU945196.1

Taricha granulosa (Rough skin newt)

68

Vasotocin V1a

AB274037

Cynops pyrrhogaster (Red bellied newt)

67

Vasotocin

AF184966

Platichthys flesus (flounder)

63

Vasotocin

AF517936

Haplochromis burtoni (cichlid)

63

Vasotocin

X76321

Catostomus commersoni (white sucker)

61

Vasotocin V1a1

HQ662334.1

Epinephelus adscensionis (rock hind)

61

Vasotocin V1a1

GQ981412

Cyprinodon nevadensis amargosae

59

(pupfish)

Vasopressin V1b

L37112

Homo sapiens (human)

54

Vasopressin V1b

D45400

Rattus norvegicus (rat)

50

Vasopressin V1b

AF098867

Mus musculus (mice)

53

Vasotocin VT2

AY008272

Gallus gallus (chicken)

53

Vasotocin V1b

XP 002189484

Taeniopygia guttata (Zebra finch)

54

Vasotocin V1b

XP 003212983

Meleagris gallopavo (Turkey)

53

Vasotocin V1b

EF567079.1

Taricha granulosa (Rough skin newt)

52
70

Vasotocin V3/V1b

AB284503

Cynops pyrrhogaster (Red bellied newt)

53

Vasotocin V1a2

HQ141396

Epinephelus adscensionis (rock hind)

63

Vasotocin V1a2

GQ981413

Cyprinodon nevadensis amargosae

60

(pupfish)

Vasopressin V2

L22206

Homo sapiens (human)

42

Vasopressin V2

Z11932

Rattus norvegicus (rat)

41

Vasopressin V2

NM019404

Mus musculus (mice)

41

Vasotocin VT1

AF147743

Gallus gallus (chicken)

48

Vasotocin V2

XP 002195418

Taeniopygia guttata (Zebra finch)

46

Vasotocin V2

XP 003202046

Meleagris gallopavo (Turkey)

47

Vasotocin V2

ABQ 23253

Rana catesbeiana (Bull frog)

45

Vasotocin V2

BAF 38755

Cynops pyrrhogaster (Red bellied newt)

43

Oxytocin OT

X64878

Homo sapiens (human)

54

Oxytocin OT

U15280

Rattus norvegicus (rat)

49

Oxytocin OT

X87986

Ovis aries (sheep)

51

Oxytocin OT

U82440

Macaca mulatta (rhesus monkey)

52

Vasotocin VT3

AY833434

Gallus gallus (chicken)

49

Mesotocin

AY277925.1

Rana catesbeiana (Bull frog)

48

Mesotocin

DQ186599.1

Taricha granulosa (Rough skin newt)

49

Isotocin

X87783

Catostomus commersoni (white sucker)

47

Isotocin

GQ981415

Cyprinodon nevadensis amargosae

53

(pupfish)
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Table 2: List of antibodies employed in the immunohistochemical study (p for polyclonal,
m for monoclonal)

Target antigen

Code

Antigen

Host

Dilution

Source

Vasotocin receptor

VT4R

Synthetic peptides

Rabbit (p)

1:2000

21st Century

(VT4R)

#3/63

corresponding to 15

Biochemicals

amino acids from

Inc.

amino terminal and 17
amino acids from
carboxy terminal
region of chicken VT4
receptor

Adrenocorticotropic

16D9

hormone (ACTH)

Native Hypophysial

Mouse(m)

1:2000

Berghman et

chicken

al.1998;

proopiomelanocortin

Gerets et
al. 2000

Prolactin

VIIA2

Synthetic peptide PD2

Mouse(m)

1:6000

corresponding to 59-

Berghman et
al. 1992

67 of chicken
prolactin

Growth hormone

IH7

(GH)

Native hypophysial

Mouse(m)

1:6000

chicken GH

Berghman et
al. 1998;
Zheng et al.
2006

Luteinising hormone
(LH)

IIIC7E10

Native hypophysial
chicken LH

Mouse(m)

1:5000

Berghman et
al. 1993
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Figure legends:
Figure 1: (A) Amino acid sequence of the VT4R with the two peptides synthesized for antibody
shown in red (N terminal) and blue color (C-terminal). (B) Amino acid sequence alignment of
the carboxy terminal region of the VT4R compared with V1aR in other species indicating the
specificity of the immunogenic site of the VT4R. (C) Amino acid sequence alignment of the
amino terminal region of the VT4R with the synthesized peptide.

Figure 2: Characterization of the antibody against chicken vasotocin receptor VT4 (VT4R) using
Western blot analysis. (A) VT4R protein extracts labeled with the antibody shows a single band
of 47KDa as predicted with a molecular weight marker (M) in HeLa cells transfected with
chicken VT4R (C1) and avian pituitary tissues (P).

This band was absent in HeLa cells

transfected with an empty expression vector (C2). (B) Specificity control of the antibody using
the peptide competition or preadsorption assay in extacts from the chicken pituitary (P) tissues.
The antibody at working dilution of 1:2000 was preincubated with 5 µg (P1) and 50 µg (P2) of
antigenic peptides prior to use in the Western blot.

Figure 3: Antiserum specificity of chicken vasotocin receptor (VT4R) using the peptide
competition or preadsorption assay in sections of chicken anterior pituitary gland. Coronal
sections of pituitary showing cells labeled by VT4R #3/63 at a working dilution of 1:2000 (A).
Antibody at 1:2000 dilution was preadsorbed with 8 µg (B) and 50 µg (C) of the antigenic
peptides prior to use in immunocytochemistry. Scale bars 5µm.
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Figure 4: Immunocytochemical detection of chicken vasotocin receptor in tranfected HeLa cells.
Confocal image of HeLa cells transfected with chicken VT4R cDNA (A). VT4R shown in red
with nuclei counterstained with DAPI (blue). Higher magnification of the VT4Rs in cytoplasm
(B). HeLa cells transfected with an empty pGEM7z expression vector lacking VT4R (C), VT1R
cDNA (D), VT2R cDNA (E) and VT3R cDNA (F). Nuclei are counterstained with DAPI. Scale
bars 8 µm (C, D, E, F), 10 µm (B), 20µm (A).

Figure 5: VT4R shown in cells in the cephalic lobe of anterior pituitary. Brightfield images
showing different arrangement of VT4Rs as individual cells (A, B) or clusters (C, D). Scale bars
20µm (A), 10 µm (B, C), 5 µm (D).

Figure 6: Avian pituitary cells containing the VT4R and distributed in cell clusters as well as in
isolated, individual cells.

(A) Low power fluorescence image of anterior pituitary showing

VT4R confined to cells in the cephalic lobe (Cp) and scarce immunostaining in caudal lobe (Cd).
The asterisk shows the boundary between the Cp and Cd lobes. (B) Higher magnification of
VT4R in the cephalic lobe of anterior pituitary.

Confocal images at higher magnification

showing different arrangements of clusters of cells (C) or individual cells labelled with the VT4R
(D) in the cephalic lobe of anterior pituitary. Scale bars 300µm (A), 50µm (B), 10µm (C), 5µm
(D).

Figure 7: Confocal microscopic images showing two types of hormone containing pituitary cells
with and without the VT4R. (A) Cells in cephalic lobe immunostained for VT4R (red), (B) Cells
in cephalic lobe stained for proopiomelanocortin (POMC) (green), (C) the merged image of cells
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showing colocalisation of POMC and VT4R. (D) Cells immunostained for VT4R (red), (E) Cells
immunostained for luteinising hormone (LH), (F) Merged image of cells colocalised with VT4R
and LH. The colocalised cells appear to be yellow in color in the superimposed image. Scale bars
10µm (A-C) and 10µm (D-F).

Figure 8: Cells in anterior pituitary immunostained for VT4R and prolactin (PRL). Low power
confocal image of cells containing the VT4R (A), PRL immunoreactive cells (B) and merged
image of VT4R and PRL immunoreactive cells (C). Scale bars 60µm.

Figure 9: Confocal photomicrographic images at the interface of cephalic and caudal lobe for
Growth hormone (GH) and VT4R immunoreactive cells stained in anterior pituitary. Cells
stained for VT4R (A), GH immunoreactive cells (B) and merged image of GH and VT4R
containing cells (C). Scale bars 10µm.
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Abstract
Arginine vasopressin (AVP) and its non-mammalian homolog arginine vasotocin mediate
their effects through G protein coupled receptors. In birds, AVT mediates its effects through
four vasotocin (VT) receptor subtypes: VT1R, VT2R, VT3R, and VT4R. Previous studies have
shown that the VT2R is absent in brain and abundant in pituitary gland. The VT4R in chickens
shares 69% amino acid homology with its mammalian counterpart V1aR, a receptor found in the
mammalian brain. Therefore the present study focussed on the VT4R to determine whether it
occurs in the avian brain. The aim of the study was to investigate the distribution of the VT4R
in the chicken brain using a polyclonal antibody developed against the amino terminal region of
the receptor. The antiserum specificity was validated using Western blot, peptide blocking
assays and immunocytochemistry.

Results indicate that the VT4R is widespread in brain

regions. Intense VT4R immunoreactive perikarya were found in the paraventricular nucleus,
supraoptic nucleus, oculomotor nucleus, Edinger Westphal nucleus, magnocellular cochlear
nucleus and nucleus of the solitary tract. Glial cells were intensely immunoreactive for the
VT4R in hippocampus, forebrain and in circumventricular organs. Data suggest that the VT4R
may play a role in central control of water balance, regulation of stress responses and sensory
functions like olfaction. Further, the VT4R is also associated with the auditory and visual
system.
Keywords: V1aR, glial cells, circumventricular organs, stress, visual system
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1. Introduction
The hypothalamic pituitary adrenal axis (HPA) is activated due to homeostatic disturbances
by secreting the neuropeptide arginine vasopressin (AVP) and corticotropin releasing hormone
(CRH). The former, in mammals, is a nine amino acid peptide arginine vasopressin (AVP)
produced in paraventricular nucleus (PVN) and supraoptic nucleus (SON) of the hypothalamus
and transported from the median eminence to the anterior pituitary.

The peptides act on

corticotropes of the anterior pituitary resulting in the secretion of adrenocorticotropic hormone
(ACTH) which inturn acts on adrenal glands to produce glucocorticoids, cortisol in some
mammals and corticosterone in birds, rats and mice. The avian neuropeptide, arginine vasotocin
(AVT), is considered homologous to the mammalian peptide arginine vasopressin (AVP)
(Landgraf and Neumann, 2004). Human AVP differs from avian AVT at the third position of its
amino acid sequence (a phenylalanine to isoleucine substitution). The neuropeptide AVP/AVT
exhibits a wide range of biological actions, functioning as a neurohormone peripherally and as a
neurotransmitter/neuromodulator centrally.

In mammals, AVP is involved in physiological

functions such as maintenance of blood pressure, electrolyte and osmotic balance,
thermoregulation and stress responses (Aguilera et al., 2008; Aoyagi et al., 2009; Bielsky et al.,
2005a; Bielsky et al., 2005b; Engelmann et al., 2004; Volpi et al., 2004) and also involved in
behaviours including social recognition, anxiety (Bielsky et al., 2004a; Bielsky et al., 2004b),
maternal care and attachment (Nair et al., 2006), affiliation and pair bonding (Insel et al, 1996;
Liu et al., 2001; Winslow, 1993; Winslow et al., 2004; Young et al., 1997; 1999), and
aggression (Ferris et al., 2000; Francis. 2002). In non-mammalian vertebrates, AVT is involved
in scent marking, mate calling, phonotaxis (defined as the ability to show orientation toward
sound) and vocal production (Boyd et al., 1997; Do-Rego et al., 2006), courtship behaviour
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(Hasunuma et al., 2010), osmoreguation (Balment et al., 1993; 2006), aggression (Goodson,
1998), stress responses and sexual behavior (Jurkevich et al., 1997; Robinzon et al., 1988).
The neuropeptides AVP/AVT act through multiple receptor subtypes in brain and pituitary to
mediate its effects. The vasopressin receptors are G protein coupled receptors and belong to the
vasopressin/oxytocin receptor family that is classified into four subtypes: vasopressin receptors
(V) V1a, V1b and V2 and oxytocin receptors (OT).

The distribution of receptors and their

functions have been identified in mammals (Table 1) (Birnbaumer, 2000; Peter et al., 1995).
Similar to mammals, birds also have four vasotocin receptor subtypes in their family to mediate
the functions of AVT, mesotocin and other related peptides.

Vasotocin receptors in non-

mammalian vertebrates are proposed to be homologous to vasopressin/oxytocin receptors in
mammals. Four avian receptors in the vasotocin family have been identified: VT1R, VT2R,
VT3R, VT4R (Baeyens & Cornett, 2006) (Table 2). The second avian receptor, VT2R, has been
proposed to be homologous to the mammalian V1b receptor. The VT2R is found predominantly
in the cephalic lobe of the anterior pituitary and plays a major role in release of ACTH in stress
responses and to lesser extent in the release of prolactin. The receptor, however, was not detected
in brain using immunohistochemistry or Northern blot (Cornett et al., 2003; Jurkevich et al.,
2005; Jurkevich et al., 2008).
The fourth receptor, VT4R, the most recently cloned vasotocin receptor has an amino acid
sequence that is 69% homologous (Table 2) with that of the mammalian V1a receptor (Cornett,
2007, unpublished). Its gene has been shown to be present in chromosome 1 of the chicken
(Scarbrough et al., 2003). Studies have been done on sequence comparisons of vasotocin
receptors in non-mammalian vertebrates with that of the human V1aR. Data suggest that in
amphibia (Acharjee et al., 2004; Mahlmann et al., 1994; Hasunuma et al., 2007), fishes (Kline et
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al., 2011; Warne, 2001) and rats (Ostrowski et al., 1994 ; Morel et al., 1993; Ostrowski et al.,
1992; Szot et al., 1994) the V1aR is homologous to the V1aR of humans (Table 2 ). It is of
interest to determine if the VT4R occurs in the chicken brain and, if so, whether its distribution
is similar to that of the rat where

V1aR mRNA has been located in olfactory lobes,

hippocampus, hypothalamic, mesencephalic and rhomboencephalic regions and in cerebellum
(Ostrowski et al., 1992; 1994). Research studies have indicated that the distribution of the V1aR
varies greatly among mammalian species and is linked to their sociality. For instance, the neural
distribution of V1aR differs between monogamous voles and polygamous voles. This difference
in distribution is associated with pair bond formation and maternal care that are exclusive
behaviors for monogamous voles (Bielsky et al., 2004; Insel et al., 1994; Leung et al., 2009;
Wang et al., 1997; Young et al., 1999; 1997). The remarkable difference in V1aR distribution in
the ventral pallidum and arcuate nucleus in a solitary and social species of a rodent, Tuco-Tuco,
is critical for maintenance of a specific social behavior in the species (Beery et al., 2008).
Further, the high expression of V1aR in the periaqueductal gray and medial geniculate nucleus in
singing mice Stenomys teguina favors vocal communication while the high expression in the
lateral thalamus and mediodorsal thalamus favors spatial working memory in S. xeramphelinus
(Campbell et al., 2009). Thus, the interspecies and intraspecies difference in V1aR distribution
may explain the variations in social behavior among different species.

It is therefore of

considerable interest to study the neural distribution of the proposed homologue of the V1aR and
its possible association with stress or social behavior in avian species as well. The objective of
the present study is to test the hypothesis that the VT4R is present throughout the brain using an
antibody directed against a partial peptide sequence produced from the VT4 receptor gene
sequence in Gallus gallus.
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2. Materials and methods:
2.1 Animals
2.1. a. Antibody validation study:
Ten septal regions, ten hypothalamic regions and twenty anterior pituitary tissues were
obtained from 6-8 week old broilers for extraction of membrane protein. Birds were decapitated
and heads placed on ice. The brain was removed from the skull and the following brain regions
and pituitary dissected (septum, hypothalamus and anterior pituitary) and frozen in dry ice. The
dissected brain regions and pituitaries were stored in vials at -80°C.

2.1.b. Receptor distribution in Brain:
Ten male broiler birds in the age group of 24-32 weeks were raised in order to sample their
brains to identify VT4R distribution throughout the brain. All birds were caged individually
under 14h light and 10h dark lighting cycle and food and water were provided ad libitum. All
animal procedures used in this study were conducted in compliance with protocols approved by
the University of Arkansas Institutional animal care and use committee.

2.2 Antibody generation specific to vasotocin receptor subtype 4 (VT4R):
Two peptides, AGDWDPFGRDEELAC corresponds to N terminal 15 amino acids (residues
45-59) and NSNSRRQTSFTNNRSPT corresponds to C terminal 17 amino acids (residues 376392) of chicken VT4R were synthesized (Cornett, 2007, GenBank submission). Polyclonal
rabbit antiserum to the chicken vasotocin receptor VT4R was raised against the two peptides.
Sequences of peptides were chosen to minimize their similarity with other known vasotocin
receptor subtypes or any other avian protein (Figure 1; GenBank accession no: XM_001235007).
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A cysteine thiol and a 6 carbon spacer were added to the C-terminal and glutaraldehyde to the Nterminal peptide for easier conjugation to the carrier protein (ovalbumin) by the use of mmaleimido benzoyl N-hydroxy succinimide (MBS).

The synthetic peptide was coupled to

ovalbumin and this conjugate was employed to immunize two rabbits with a two week interval
between boosters. The rabbits were bled 10 days post immunization, starting after the third
booster administration.

2.3 Affinity purification of VT4R specific antibodies:
The synthetic N terminal and C-terminal peptide were coupled individually to the free
sulfhydryl group of its C-terminal cysteine residue of iodoacetyl gel (Biorad, CA, USA) at a ratio
of 1mg of peptide per 1ml of Gel in Tris/EDTA buffer for use as an immunoadsorbent. For the
isolation of peptide-specific antibodies, 47 ml of serum were mixed with the immunoadsorbent
(50ml). The non-specific antibodies were rinsed away with 60 ml of salt buffer. Antibodies
specific to the peptides were eluted with 100mM Glycine-HCl buffer pH 2.5 and immediately
neutralized with 1M Tris buffer pH 9.5. The concentration of eluate (N-terminal and C-terminal
antibody) was quantified individually using absorbance at 280 nm. The production and affinity
purification of the antibody was completed by 21st Century Biochemicals (Marboro, MA).
Immune serum obtained from both rabbits produced adequate staining pattern on brain sections.
The best immunocytochemical result for brain sections was obtained from rabbit 2 (#4364) N
terminal peptide (termed as VT4 #1) after 4 or more booster injections.
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2.4 Membrane protein extraction and Western blotting:
Septal region, hypothalamic region and pituitary tissues were used for the extraction of
plasma membrane protein using plasma membrane protein extraction kit (Biovision, CA, USA).
Briefly, the tissues were homogenized with a buffer mix provided in the kit. The total cellular
membrane proteins were pelleted at 10,000 g for 30 min at 4°C. The pellet was resuspended in
200 µl of upper phase buffer and lower phase buffer. The plasma membrane proteins were
obtained in pellets after centrifugation at 1,000 g for 5 min followed by a final spin at 20,000 g
for 10 mins.

Protein concentration in each homogenate was determined using RC/DC Protein

Assay kit-II (Biorad, CA, USA). The protein lysates of concentration 40µg was diluted using a
ratio 1:1 with 6X Laemmli sample buffer containing SDS and β-mercaptoethanol and heated for
15min at 90°C.
Samples were loaded onto a 12% sodium dodecyl sulphate-polyacrylamide gel.

The

separation of protein takes place at 180V for 55min (Biorad, CA, USA). The proteins were
transferred to a nitrocellulose membrane (0.25A for 70 min) using Tris-Glycine buffer pH 9.5.
Non-specific binding to the membrane was achieved by treating the membrane with 5% non-fat
milk for 30mins. All antibodies were diluted in tris buffered saline (TBS) buffer with 5% nonfat milk. Each membrane extract was incubated with an antibody raised in rabbit against VT4R
at a dilution of 1:1000 overnight at 4°C. Simultaneously, anti-rabbit VT4R IgG against the Nterminal peptide was preincubated in blocking buffer for 3 hrs at room temperature with serial
amounts of peptide (5 µg and 20 µg). The antibody-peptide mixture was centrifuged at 14,000
rpm for 30 min. The supernatant served as the primary antiserum. Membranes were washed with
TBS for three changes. Later the membrane fraction was incubated with horseradish peroxidase
conjugated with goat anti-rabbit IgG (dilution 1:12,500, Santa cruz Biotechnology, CA, USA)
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for 1hr. Bands were visualized using Pierce Super Signal Femto Maximum Sensitivity substrate
kit (Pierce, Thermoscientific, USA) according to the manufacturer`s instructions followed by
exposure to Kodak Biomax Maximum Resolution (MR) autoradiography film (Carestream
Health, USA). Images were scanned and compiled in Adobe Photoshop CS5.

2.5 Detection of VT4R in cell lysates:
The chicken VT4R subtype was transiently transfected with 2.8 µg of expression vector
pCDNA3 containing VT4R cDNA or pGEM7Z lacking VT4R using Lipofectamine 2000
method (Invitrogen, CA, USA) (Davis et al., 2000). The cells were cultured in growth medium
containing 10% Fetal bovine serum (FBS) and Eagle`s minimum essential medium (MEM) at
37°C and incubated in a 5% CO2 incubator. Twenty four hours later, the medium was removed
and replaced with fresh medium. Seven to ten days after post transfection, the VT4R cells were
scrapped off from the plates and resuspended in PBS. Cells were centrifuged at 14,000rpm for
15min. The pelleted cells were then rinsed with PBS, supernatant removed and frozen in liquid
nitrogen. The cell count for cells containing VT4R was estimated to be 6.5X10 7 per 1.5ml. The
pCDNA3-VT4R vector served as a positive control while pGEM7Z plasmid served as a negative
control. The membrane protein from cell lysates was extracted using a plasma membrane protein
extraction kit (Biovision, CA, USA).

Western blotting was performed on cell lysates as

described in section 2.4.
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2.6 Immunohistochemistry
2.6.1 Tissue collection:
Birds were anaesthetized by administering sodium pentobarbital intravenously (40mg/kg i.v).
Birds were perfused through carotoid arteries with 250ml of heparinized phosphate buffer (0.1M
PB with 0.1% sodium nitrite, pH 7.4) followed immediately by 400ml of Zamboni`s fixative pH
7.4 (4% paraformaldehyde in 0.1M PB, 15% saturated picric acid). Brains were blocked in a
stereotaxic instrument (Kopf Instruments, CA) and placed in the same fixative for overnight
postfixation at 4°C. Brains were then placed in 30% sucrose solution (in 0.1M PB buffer) at 4°C
until the brains sank to the bottom, then frozen in dry ice, sealed in parafilm and stored at -80°C
until processed for immunohistochemistry.
Brains were embedded in Jung tissue freezing medium (Leica Instruments, Germany). Four
sets of 40 µm thick coronal sections were sectioned using a cryostat. (Leica CM 3050S, Leica
Microsystems, Frisco, TX) and preserved in cryoprotective solution pH 7.2 at -20°C. The
collected sections covered the brain structures located in the stereotaxic anterior-posterior plates
A14.8 to P4.0 of a chick brain atlas (Kuenzel and Masson, 1988). One set was used to map the
distribution of the VT4R while three sets were kept as backups.

2.6.2 Immunohistochemistry:
Sections were rinsed in several changes of 0.02M PBS to remove the cryoprotective solution.
It was then treated with 0.6% hydrogen peroxide to quench endogenous peroxidase activity and
permeabilized with 0.4% Triton X-100. After rinsing with PBS, sections were incubated with
5% normal goat serum for 30min to block non-specific binding sites. Sections were incubated for
40hrs at 4°C with VT4R antibody raised in rabbit (at a dilution of 1:2000 in 0.02M PBS with 1%
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NGS, 0.2% Triton X-100 and 0.1% sodium azide). Sections were incubated for 90min with
biotinylated goat anti-rabbit IgG (dilution 1:500 in 0.02M PBS with 0.2% Triton X-100) (Vector
laboratories, CA, USA) followed by incubation with Vectastain Elite ABC peroxidase complex
diluted 1:5 for 90 min (Vector laboratories, CA, USA). The VT4R immunoreactive cells were
visualized using glucose-oxidase diaminobenzidine nickel (Shu et al., 1988). The reaction was
stopped in a 2-3min short rinse with acetate buffer. Sections were rinsed in PBS for two
changes, rinsed with deionized water, mounted onto clean glass slides and coverslipped with
Histamount (National Diagnostic Laboratories, Atlanta, USA).

2.6.3 Antisera specificity control:
Rabbit antiserum VT4 #1 was preadsorbed with the N terminal VT4R peptide used to
immunize the rabbits. Antiserum in working dilution 1:2000 was preincubated with increasing
amounts of peptide (10µg and 50µg) for 3hr at room temperature.

The peptide-antibody

complex was centrifuged at 14,000 rpm for 30min and the supernatant applied to brain sections.
Sections were processed for immunohistochemistry as described in section 2.6.2. Additional
controls included omission of primary and secondary antibodies from the immunohistochemical
protocol described in section 2.6.2.

2.7 Transfection of HeLa cells with VT4R:
HeLa cells were plated onto a four chamber slide (Lab Tek-II chamber slide system,
Rochester, NY) at a concentration of 2X105 cells per chamber in 1ml of growth medium (10%
Fetal bovine serum and Eagle`s minimum essential medium), cultured at 37°C in a humdified
5% CO2 incubator overnight. After twenty fours later, cells were transiently transfected with
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2.8µg of expression vector pCDNA3 containing a cDNA encoding the chicken VT4 receptor in
50µl Opti MEM

per chamber or pGEM7-Z lacking VT4R, using Lipofectamine 2000

(Invitrogen, CA, USA) method (Davis et al., 2000). Forty eight hours post transfection, the cells
were fixed with 4% paraformaldehyde (in 0.1M PBS, pH 7.4) for 15min at room temperature.
The cells were then rinsed with PBS and air dried at 4°C and kept in air-tight boxes until
processed for immunocytochemistry. To determine whether the antibody is able to specifically
recognize cells containing the VT4R in brain, immunocytochemistry was performed on HeLa
cells transfected with cDNA encoding VT1R, VT2R or VT3R cloned into pCDNA3 in addition
to pCDNA3-VT4 cells. The transfected HeLa cells plated onto four chamber slides were
prepared by Sandie Jacoby (University of Arkansas for Medical Sciences).

2.7.1 Immunofluorescence
The tranfected HeLa cells were subjected to immunofluorescence. Slides with cells were
rinsed in PBS and permeabilized with 0.4% Triton X-100. To block the nonspecific binding
sites, cells were treated with 10% normal donkey serum (NDS) (Jackson immunoresearch, PA)
for 30min in a humidified chamber. Slides were then incubated with rabbit antiserum VT4 #1 (at
a dilution of 1:500 in TBS with 1% NDS) for 40hrs in a humidified chamber at 4°C. After a
brief rinsing in PBS, slides were incubated with Dylight 594 donkey anti rabbit IgG (dilution
1:400, Jackson Immunoresearch, PA, USA) for 90min in a humidified chamber. The slides were
rinsed in three changes of PBS followed by a short rinse with deionized water. The slides were
coverslipped with Vectashield mounting medium (Vector Laboratories, CA). Cell nuclei were
counterstained with DAPI.
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2.8 Imaging
Sections were observed using a Zeiss Axioplan 2 imaging microscope (Carl Zeiss, NY).
Digitized images were taken using a CCD camera (Orca-ER camrea, Hamamatsu, NJ) and
simple PCI software (Compix Imaging systems, Cranberry Township, PA).
photomicrographs were prepared in Adobe Photoshop CS5.

The

Digitized schematic diagrams of

the atlas of the domestic chick brain (Kuenzel and Masson, 1988) were used to map the
anatomical structures identified by VT4R immunoreactive cells. The brightness and contrast was
adjusted in Adobe Photoshop CS5. No image transformation was performed.

3. Results
3.1 Antiserum specificity:
(a) Western blot:
The specificity of the antibody VT4#1 was validated using the Western blot technique with
membrane protein extracts from chicken hypothalamus, septal regions and pituitary tissues. The
antibody presented a strong band at 45-47KDa with the chicken tissues as estimated by a
molecular weight ladder. The 47KDa band was also present in HeLa cells transfected with the
expression vector encoding chicken VT4R cDNA, however, was absent in non-transfected HeLa
cells (expression vector pGEM7z lacking VT4R) (Fig 2A).

In the peptide competition

experiment, the antibody preadsorbed with 5µg of peptide significantly reduced the intensity of
band while 20 µg of peptide eliminated the band completely (Fig 2B).
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(b) Immunocytochemistry:
The specificity of the antibody was further validated utilizing a peptide competition assay
with coronal brain sections. The antibody VT4 #1 was preadsorbed with 10 µg of the peptide
used to produce the antibody. The procedure reduced the intensity of staining drastically while
eliminated the staining completely when preadsorbed with 50 µg of the same peptide (Fig 3).
Further, the antibody VT4 #1 was tested on HeLa cells transfected with VT receptor subtypes
to confirm the specificity of the antibody. The VT4 #1 antibody had intense staining with HeLa
cells transfected with chicken VT4R cDNA. Almost all cells immunolabelled for VT4R had a
whole cell profile (Fig 4A, 4B, 4C). About 50% of cells had imunoreactivity in the cell body and
processes (Fig 4B). The cell body staining was present in or about the plasma membrane of the
cells (Fig 4B, 4C). Absence of immunoreactivity with the antibody VT4 #1 was found with
HeLa cells transfected with plasmid pGEM7Z (Fig 4D), and HeLa cells transfected with
expression vectors encoding VT1R cDNA (Fig 4E), VT2R cDNA (Fig 4F) and VT3R cDNA
(Fig 4G).

3.2 Distribution of VT4R in brain:
The VT4 #1 antibody was used on coronal brain sections to determine the distribution of
VT4R in male chicken brains. The abbreviations shown on schematic diagrams of brain sections
are shown in Table 3.

The distribution of VT4R immunoreactive perikarya and VT4R

immunoreactive glial cells are summarized in Figure 5. The VT4R is widely distributed in brain
and an abundant receptor present in chicken brain. The VT4R immunostains both neurons and
glia. The VT4R distribution is organized in the following figures and tables into VT4R
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immunoreactivity identified in perikarya followed by VT4R immunoreactivity shown in glial
cells.

3.2.1. VT4R immunoreactive perikarya:
3.2.1.1 Telencephalic regions:
In the globus pallidus, numerous cells expressed a strong immunoreactivity with the VT4R
antibody (Fig 8D). Dense VT4R immunoreactive cell bodies and processes were seen with the
periventricular preoptic nucleus. Intense VT4R perikarya were observed in the fiber tracts of the
lateral forebrain bundle (Fig 5C-5D).

3.2.1.2 Thalamic regions:
In thalamic regions, the immunostaining of VT4R varies from weak to strong. The weak
immunoreactivity was observed in the lateral habenular nucleus. A moderate immunoreactivity
of VT4R was observed in nucleus dorsomedialis posterior thalami, nucleus dorsointermedius
posterior thalami, nucleus dorsolateralis anterior thalami, nucleus geniculatus lateralis (GLv) and
in nucleus reticularis superior (RSd).

An intense immunoreactivity was found in nucleus

rotundus (Fig 5E-5H).

3.2.1.3 Hypothalamic regions:
In general, the hypothalamic regions were intensly stained with VT4R. The structures that
line the third venticle namely the paraventricular, periventricular and supraoptic nuclei had
intense VT4R immunoreactivity in their perikarya and in cell processes (Fig 5E-G, 6).
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3.2.1.4 Mesencephalic regions:
Strongly labeled immunoreactive VT4R perikarya were found in dorsomedial, dorsolateral
and ventral portions of oculomotor nuclei and Edinger Westphal nucleus (Fig 5I, 89B). Intense
VT4R immunoreactivity was observed in the magnocellular isthmus nucleus while weak staining
was observed in parvocellular isthmus nucleus, central gray and intercollicular nucleus.
Moderate immunoreactive cells were found in mesencephalic nucleus (MLd and MPv) (4I-4K).

3.2.1.5 Pontine regions:
Strong immunoreactive VT4R perikarya were found in magnocellular cochlear nucleus
(MCC), laminar nucleus (La) (Fig 5N, 10B) and lateral reticular nucleus paragigantocellularis
(RpgI) (Fig 5N). Moderate staining was seen with cranial nerves V, VI, VII in the structures
namely sensory nucleus of principal trigerminal nerve (nPrV), motor nucleus of trigerminal
nerve (MnV) (Fig 11C, 11D), nucleus of abducens nerve (nVI) (Fig 9D), dorsal (MnVIId; Fig
11E) and ventral portion of motor nuclei of facial nerves (MnVIIv) (Fig 5K-L). The presence of
VT4R in these cranial nerves might aid in somatic sensation of the face, facial expressions and
movement of muscles for mastication (Fig 11) (Bears et al., 2000; Paxinos et al., 2004).A weak
immunoreactivity of VT4R was observed in subceruleus nucleus (SCd and SCv), leminiscus
lateral nucleus (LLd and LLi), lateral pontine and medial pontine nuclei (Fig 5K-5L).

3.2.1.6 Cerebellum:
Intense labelled VT4R immunoreactive perikarya were observed in internal and intermedial
cerebellar nuclei (CbI and CbIM). Purkinje cells of cerebellum were very weakly stained with
VT4R (Fig 5L-O, 12B, 12D).
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3.2.1.7 Medulla:
The subtrigerminal reticular nucleus (RST), medial and lateral vestibular nuclei (VeD, VeL;
Fig 10C), nucleus of solitary tract and nucleus supraspinalis were strongly immunostained with
VT4R. The staining was characteristic of cell body with long densely stained processes (Fig
5M-P). The cranial nerves namely glossopharyngeal nucleus, motor nucleus of vagal nerve and
hypoglossal nucleus were also immunostained for VT4R very strongly (Fig 5M-P).

The

presence of VT4R in hypoglossal nucleus suggests that it might provide motor innervation to the
muscles of tongue (Paxinos et al., 2004).
The intensity of VT4R perikarya in neuronal structures are shown in Table 4(a).

3.2.2 VT4R immunoreactive glia:
3.2.2.1 Telencephalic regions:
In the olfactory bulb, there were intense immunoreactive of glial cells in layers of olfactory
ventricles including internal plexiform layer, external plexiform layer, mitral cell layer and
glomerular layer. The glial cells move mediolaterally and mediodorsally from the ventricles and
terminate either in bulbus olfactorius or in granule cell layer of olfactory ventricles (Fig 5A, 7A).
Numerous small round cells were immunostained in nucleus basorostralis pallii and entopallium
that lacked a distinguishable cell processes. They are termed as glial elements due to the smaller
size of glia compared to neurons. The glial elements could be radial glia in nature. Some glial
cells originating from the ventricles travel towards the hyperpallial structures including
hyperpallium apicale, lamina frontalis superior and lamina frontalis suprema in forebrain (Fig
5A-5C) and also gets terminated in these regions. The glial cells in lateral septum were densely
stained for VT4R, which originate from the walls of the lateral ventricle. Glial cells originating
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from the ventral lateral walls of the lateral ventricle send long processes laterally to different
parts of the brain that line the third ventricle while the dorsal lateral walls of the lateral ventricle
send the processes to the pallium and striatum (Fig 5C-F, 7B). There were few glial elements
observed in the medial septum. The glial cells in the hippocampus originate predominantly from
the medial dorsal wall of the lateral ventricle. The VT4R immunoreactive glial cells in
hippocampus are characterized by a small densely packed cell body and long protruding
processes. The radial glial cells originating from dorsal portion of Hp move medially to midline
while the glial cells originating from ventral portion of Hp reach different parts of the brain. The
long processes are observed in glial cells on ventral side rather than on dorsal side (Fig 5D-F,
6E).

3.2.2.2 Diencephalic regions:
Very densely packed VT4R immunoreactivity of glial cells was observed in the inferior
hypothalamic and infundibular hypothalamic nuclei. The cell bodies are small and stained very
intensely while the processes are very long, protruding fibres from the third ventricle moving
laterally (Fig 5G-H, 7F). The glial cells that are stained in this region could be tanycytes. The
medial portion of interstitial nucleus and mesencephali nucleus of central gray (GCt) also had
glial cell VT4R immunoreactivity.

3.2.2.3 Mesencephalic regions:
The periventicular nucleus of stratum griesum had intense short glial cells immunostained for
VT4R moving laterally to other regions of the brain (Fig 5I-J).
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3.2.2.4 Cerebellum:
The molecular layer of cerebellum has intense glial cell staining of VT4R characteristic of
Berghmann glial cells. Such glial cells run perpendicular to the cerebellar surface (Fig 5M-O,
12C).

3.2.2.5 Medulla:
The central canal in the medulla has very dark immunostaining of VT4R in glial cells and
the staining is observed around the fourth ventricle (Fig 5P). The central canal continues to the
spinal cord.

3.2.2.6 Circumventricular organs:
The VT4R immunoreactivity was observed in all circumventricular organs (CVOs) (Fig 5CP, 12). The lateral septal organ (LSO) identified in birds (Kuenzel and van Tienhoven, 1982) is
the most anterior CVO. It was shown to be composed of two components, a medial (LSOm) and
lateral (LSOl) portion (Walsh et al., 1997; Kuenzel and Blahser, 1994). Of interest is that both
portions have glial cells immunostained for VT4R as the glia are located at the base of the lateral
ventricle and are continuous around the medial wall of the lateral ventricle and move around the
base of the VL and up the lateral wall of the VL. The glia along the medial wall of the lateral
ventricle originate in the septum and their processes move medially into the LSOm. Glia along
the lateral wall of the VL originate in the pallidum and their processes move away from ventricle
to different regions of the brain including pallidum and striatum (Fig 13D). The second CVO
encountered is the organum vasculosum of the lamnia terminalis (OVLT).

The VT4R

immunolabelled glia are intensely stained along the wall of the third ventricle and their processes
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move laterally from midline into the preoptic and hypothalamic regions. As originally described
by Dellmann et al., (Dellmann et al., 1964) and clarified by the distribution of gonadotropinreleasing hormone sub-type 1 (GnRH-1) neurons (Kuenzel and Golden, 2006), the OVLT moves
dorsally and passes in front of the anterior commissure.

As it moves over the anterior

commissue it appears to merge with the nucleus of the hippocampal commissure (HpC) formerly
called the bed nucleus of the pallial commissure (NCPa) (Fig 13E). Posteriorly, the OVLT-HpC
complex becomes a third CVO, the subseptal organ (SSO) that has a finger-like projection from
the roof of the third ventricle into the chamber of the third ventricle.

It has VT4R

immunolabelled glia whose processes enter the septum and dorsal thalamus (Fig 13F).
Choroid plexus is a complex group of blood vessels that resides in the enlarged ventral horns
of the lateral ventricles that merge with the dorsal region of the third ventricle. Choroid plexus
is tightly connected by epithelial cells which encloses a loosely connected by capillaries and is
responsible for the secretion of cerebrospinal fluid (CSF) (Strazielle et al., 2000; Strazielle et al.,
2005). The plexus is densely immunostained with VT4R antibody suggesting a large number of
ependymal glial cells associated with the capillaries comprising the plexus (Fig 13C). The next
circumventricular organ, paraventricular organ forms a bilateral small groove on the walls of the
third ventricle. It lies caudal to the paraventricular nucleus and extends ventrocaudally from the
mid hypothalamic regions to medial mammilary nucleus (Kuenzel and van Tienhoven 1982;
Vigh, 1970; Guglielmone, 1995). Paraventricular organ has short glial fibres immunolabelled for
VT4R characteristic of ependymal cells (Fig 13H).
Median eminence is an important circumventricular organ which is the ventral most region of
the hypothalamus. It forms the floor of the third ventricle. Its dense immunostaining suggests a
large number of VT4Rs occur in glia known as tanycytes. Both internal zone and external zone
101

of median eminence are immunolabeled. It has radially directed processes of glia (proposed
tanycytes) that originate at the base of the third ventricle and curve ventrally toward the base of
the brain (Fig 13I).
The pineal gland is devoid of neurons and has glia and pinealocytes.

Glial cell staining

(proposed to be ependymal cells) of VT4R was observed in pineal gland (Fig 13J). Pineal gland
in birds is found to be involved in the release of melatonin (Natesan et al., 2002) and in control
of daily and seasonal rhythms (Csernus et al., 2006).
The subcommissural organ (SCO) lies in posterior portion of third ventricle and leads to the
cerebral aqueduct. Glial cells immunoreactive of VT4R were observed proposed to be
ependymal and hypependymal glial cells. The processes are long projecting fibers running from
the walls of the ventricle into midbrain regions (Fig 13G). The SCO might participate in the
circulation of cerebrospinal fluid (CSF) or clearance of compounds from CSF though the exact
pathway is unknown (Rodriguez et al., 1998).
The Subtrochelar organ (STO) is an organ found in the chicken brain (Kuenzel and van
Tienhoven, 1982) that has specialized ependymal cells.

These ependymal cells are

immunoreactive for VT4R. The organ possesses the form of alphabet ‘V’ located in posterior
walls of the mesencephalon. The apex of the structure has a bulb shaped projection which has
intense glial cells stained for VT4R. The arms of the organ are directed rostrolaterally, which
possess small cell bodies along the walls of the organ while the cell processes project to the apex
of the organ (Fig 13K).
Area postrema is present in the fourth ventricle and is heavily stained VT4Rs present in glial
cells (suggestive of modified ependymal cells). The cell processes are very dense staining of
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VT4R. The processes of the glial cells move from the area postrema into the perivascular space
while few processes extend beyond and reach the central canal. It helps in the baroreflex and
cardiovascular control as well as the autonomic control of systems involved in feeding and
mechanism (Price et al., 2008; Fig 13L).
The intensity of VT4R immunoreactivity in glia is summarized in Table 4(b).

4. Discussion
4.1 Antiserum specificity:
To determine the distribution of VT4R in brain, a polyclonal rabbit antiserum was developed
against 15 amino acids from amino terminal region of the VT4R. The antibody was validated
before use in determining the receptor distribution. The antibody was validated utilizing three
different techniques: a Western blot on chicken tissues and transfected cells, peptide blocking
experiments using both Western blots and immunocytochemistry and immunocytochemistry on
HeLa cells transfected with VT receptor subtypes (Bordeaux et al., 2010; Burry, 2000; Michel et
al., 2009; Rhodes and Trimmer, 2006). The Western blot showed that the VT4R protein was
detected with a mass of 47KDa in extracts of chicken tissues. The estimated band size is of
reasonable agreement with the observed band as the receptor is calculated to be 46.2KDa based
on its molecular weight comprising 419 amino acids (Fig 2A). The band was absent in non
transfected HeLa cells (Fig 1A). When the antibody was preincubated with peptide prior to use
in Western blot, the band at 47KDa disappeared (Fig 2B).
The VT4 #1 antibody immunostained neurons and glia using coronal brain sections and
imunocytochemistry. The staining was abolished when the peptide-antibody complex (50 µg of
peptide to 5 µg of antibody) was used as a control for immunocytochemistry (Fig 3). Additional
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controls included the omission of primary and secondary antibodies from the protocol of
immunocytochemistry (data not shown).

In order to ascertain the antibody recognizes

specifically VT4R and not other subtypes, immunocytochemistry was done on cell cultures. The
results clearly indicate an intense staining of the cell body and processes with cells transfected
with expression vector encoding chicken VT4R cDNA (Fig 4A, 4B, 4C).

Absence of

immunoreactivity was found in non transfected HeLa cells (Fig 4D), transfected cells with
expression vector encoding chicken VT1R cDNA (Fig 4E), VT2R cDNA (Fig 4F) and VT3R
cDNA (Fig 4G).

4. 2 Distribution of VT4R in brain:
The current study describes the distribution of VT4R in the male chicken brain. The receptor,
VT4R, is widely distributed in the brain from olfactory bulbs to caudal medulla (Fig 5). The
VT4R is an abundant receptor in the avian brain. The intensity of staining varies from weak to
intense (Table 4). The expression of the VT4R was observed in neuronal cell bodies as well as
in glia. It also immunostained an endocrine gland, the pineal, and choroid plexus which lack
neurons. This indicates that AVT mediates its effect through VT4Rs in neurons as well as nonneuronal elements which suggests that the VT4R may play a role in various physiological
functions in birds. The VT4R has high expression levels in supraoptic, paraventricular, Edinger
Westphal, oculomotor and nucleus solitary tract nuclei. All circumventricular organs in the
chicken were immunostained for VT4R in glial cells.
The VT4R shares 69% sequence homology with mammalian V1a receptors and 65%-85%
homology with the proposed V1a receptors identified in non mammalian vertebtrates (See Table
2).

In rats, V1a receptors were identified in the following structures: olfactory bulb,
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hippocampus, paraventricular nucleus, cerebellum, raphe nuclei, choroid plexus, subfornical
organ, area postrema, solitary tract nucleus, pineal gland and lateral habenular nucleus (Morel et
al., 1993; Ostrowski et al., 1992; Ostrowski et al., 1994; Szot et al., 1994). The present study
also showed the presence of VT4R immunoreactivity in comparable structures. Nevertheless
regions like suprachiasmatic nucleus, bed nucleus of stria terminalis, amgydala, ventromedial
nucleus had V1a immunoreactivity in rats but not in avian species. In contrast, the VT4R is
distributed throughout the circumventricular organs, in cranial nerves V, VI, VII and VIII and in
neural structures including Edinger Westphal nucleus, oculomotor nucleus, dorsal and medial
portion of vestibular nucleus and magnocellular cochlear nucleus.

Comparing the receptor

distribution of VT4R with fishes (Kline,R.J. 2011), newts (Hasunuma,I. 2010; Hasunuma,Itaru
2007) and songbirds (Leung et al., 2009; 2011) revealed that there are comparable structures
that are immunoreactive for VT4R such as layers of olfactory lobes, hippocampus,
paraventricular nucleus, molecular layer of cerebellum, hypoglossal nucleus and nucleus of
solitary tract, potentially indicating that the V1aR distribution for AVT/AVP has been relatively
conserved among different species.

4.3 Potential roles of VT4 receptors:
Based on wide distribution of VT4R, its AVT mediated functions can be elucidated. The
presence of immunoreactive VT4R perikarya in neuronal structures namely parventricular
nucleus, supraoptic nucleus and presence of

glial cells immunolabelled for VT4R in

hippocampus and median eminence indicates that the VT4R might play a role in stress responses
(Aguilera et al., 1994; Engelmann et al., 2004; Holmes et al., 1986). The VT4R is also present in
corticotropes in the cephalic lobe of the pituitary (see chapter on pituitary gland) and therefore

105

helps in the release of ACTH. These data lends support that the VT4R is associated with stress
responses (Figure 6).
Social recognition in mammals begins with the detection of the pheromones from the
conspecific. The pheromones are detected by vomeronasal organ (VNO) which projects to the
accessory olfactory bulb (AOB) and the olfactory epithelium projects to the main olfactory bulb
(MOB). The AOB and MOB project to higher brain regions including piriform cortex (Cpi),
medial amgydala (MeA), lateral septum (LS) and hippocampus (Hp) that are associated with
AVP mediated social recognition or memory processes. It is suggested that the pheromone
signals are released by major urinary proteins (MUPs) to the olfactory bulb while AVP
modulates these signals in higher brain regions in order to generate a specific response (Ferguson
et al., 2002; Bielsky et al., 2004). In contrats to mammals, the olfactory system in birds lacks the
VNO and AOB. Hence, the olfactory signals are received by MOB and project to piriform
cortex, the most dominant pathway in birds, which is also associated with AVP mediated social
recognition (Jones, 1997; Kuenzel,1989; Gomez, 2008; Albers, 2011). Previous studies in rats
have shown that the olfactory lobes aid in olfaction and process the olfactory information to
lateral septum of the brain thereby aiding in social recoginition (Bielsky et al., 2005). In
mammals, V1a receptors is abundant in lateral septum, ventral pallium and periaqueductal gray,
lesions in these areas abolish social recognition or pair bonding formation, anxiety and
aggressive behavior (Bielsky et al., 2004; Bielsky et al., 2005; Liu et al., 2001). The presence of
VT4R immunoreactive glial cells in olfactory ventricles, lateral septum and hippocampus might
aid in processing information or sense from the olfactory lobes to higher brain regions. It also
suggests that the VT4R could be associated with social recognition and/or memory processes
(Fig 7).
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Many structures have been identified for classical monoamine neurotransmitter systems
that had high and moderate levels of VT4R immunoreactivity including the raphe nucleus, a
serotonin producing region; ventral tegmental area and substantia nigra, a dopamine producing
region; area postrema producing both serotonin and noradrenaline (Bear et al., 2000; Paxinos et
al., 2004; Rink and Wullimann, 2002). Therefore it could be possible that VT4Rs mediate AVT
actions on these neurotransmitter systems (Fig 8).
The basal ganglia consist of neocortex, striatum, globus pallidus, substantia nigra,
subthalamic nucleus and ventral lateral nucleus. The substantia nigra and caudate putamen of
striatum serves as input to basal ganglia while globus pallidus serves as an output to thalamic
nucleus. The basal ganglia in mammals aids in motor control (planning, coordination and
execution of movements) and learning (Reiner et al., 2005; Bear et al., 2001). The direct
pathways of basal ganglia aids in releasing motor movement while the indirect pathway of basal
ganglia aid in inhibiting the motor movement. In the direct pathway, the substantia nigra excites
the putamen neurons by releasing dopamine. The GABAergic neurons in putamen inhibit the
globus pallidus neurons which releases the cells in ventral lateral nucleus. The ventral lateral
nucleus gets activated and releases glutamate neurons to cortex which projects its neurons to
motor area of the cortex and aid in motor movement. Both globus pallidus and substantia nigra
contain dopamine and vasopressin. The vasopressin might serve as excitatory input to substantia
nigra and hence could be associated with dopaminergic pathways of this region and hence in
motor control (Reiner et al., 2005; Paxinos et al., 2004; Cross et al., 1983). Based on this
evidence, we suggest that the VT4R mediates the effects of vasotocin in motor movements,
which is further supported by the presence of VT4R in globus pallidus and substantia nigra (Fig
8).
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The visual system in avian brain includes both tectofugal and thalamofugal pathways. The
sensory fibers project to outer layers of optic tectum (TeO). This tectum projects bilaterally to
the thalamic structure, nucleus rotundus (RoT) which further projects to entopallium formerly
called ectostriatum. Entopallium cells project to entopallial belt (Ep) which inturn projects to
different forebrain structures (Gunturkun, 2000; Kuenzel 1989). The presence of VT4R in the
structures optic tectum, entopallium and in nucleus rotundus suggests that the receptor might be
involved in vision. This is further supported by the presence of VT4R in lateral geniculate
(GLv) nucleus, the major target in the thalamofugal pathway that transmits visual information
(Bear et al., 2000). Further, the oculomotor nucleus, accessory oculomotor nucleus and the
abducens nucleus receive projections from pretectum that functions to regulate constricution and
dilation of the pupil size (Dubbeldam, 2000). The VT4R expression in structures like Edinger
Westphal nucleus, abducens nucleus and oculomotor nucleus indicates a potential role in
movement of eye (extraocular) muscles, control of the pupils and provides parasympathetic
control of pupil size. Therefore, it is possible that VT4R is involved in visual pathways for
vision and in reflex pathways mediating pupillary contriction (Fig 9).
The cochlear afferents enter magnocellular cochelar nucleus (MCC) which projects to the
laminar nucleus (La). The laminar nucleus further projects to nucleus of lateral leminiscus in the
midbrain. The midbrain nucleus has different projections. The dorsal and ventral portion of
lateral leminiscus projects to the mesencephalic nucleus and to nucleus ovoidalis while the
intermedial leminiscus projects to the basalrostral palli nuclei in the forebrain (Arends et al.,
1988; Necker, 2000). In mammals, these structures are involved in auditory pathways which
suggest that VT4R might play a role in hearing and balance (Phillips et al., 1988). In avian
brain, VT4R expresssion was observed in the magnocellular cochelaris nucleus, dorsal and
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intermedial lateral leminiscus (LLd and LLi), dorsal mesencephalic nucleus (MLd), nucleus
ovoidalis (OV) and basalrostral palli nuclei formerly called nucleus basalis (Bas) suggesting its
association with the ascending auditory pathway (Fig 10).
The circumventricular organs (CVOs) are specialized structures positioned around the margin
of the ventricles in the midline of the brain. All CVOs lack the blood brain barrier (Ganong et
al., 2000).

Their location in relation to the ventrical cavities are to be noted.

The

circumventricular organs organum vasculosum lamina terminalis, pineal gland and median
eminence line the ventricular recesses while other CVOs including sub-septal organ,
paraventricular organ, subcommissural organ, subtrochlear organ and area postrema are present
at the confluence between the ventricles.

Further, the CVOs are classified as secretory CVOs

(ME) and sensory CVOs (OVLT, SSO, APa). The secretory CVOs releases neurohormones into
the blood because of the special permeability of fenestrated capillaries (Duvernoy, 2007) while
the sensory CVOs are sensible to blood borne substances and transmit this information to the
central nervous system (Johnson et al., 1993; Johnson et al., 1984). Previous studies in mammals
have shown that the CVOs is involved in pathways controlling the CSF osmolarity and pressure
(Duvernoy, 2007). In birds, the sensory CVOs are involved in thirst control and water balance
(Fahrenholz et al., 1993). The presence of VT4R glial cells in circumventricular organs lateral
septal organ, organum vasculosum lamina terminalis and area postrema might help in body
fluid regulation, autonomic regulation and endocrine function (by releasing hormones into the
bloodstream). The VT4R in tanycyte type of glial cells in median eminence suggests that it aids
in the release of hormones into the hypophysial portal system. The immunoreactive VT4Rs in
subcommissural organ, subtrochlear organ, paraventricular organ might play a role in the
secretion or circulation of CSF. To sum up, the immunoreactive VT4R in circumventricular
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organs are associated with the CSF osmolarity control, fluid balance, autonomic and endocrine
functions (Fig 13).
Considering the robust distribution of VT4R in brain, the most probable functions of the
receptor have been identified based upon VT4R immunoreactivity in neurons and glia.
Distinctive areas associated with a wide range of functions including behavior, physiological
functions like regulation of water balance, stress responses, sensory functions such as vision, and
hearing have been identified.

5. Conclusion:
The present study provides the evidence of extensive VT4R distribution in the chicken brain.
The receptor is observed in neurons and glia and found in olfactory, auditory and visual systems
and in stress responses.Based on VT4R immunoreactivity, the following functions of the
receptor have been proposed: neuroendocrine function of stress responses, social behavior,
regulation of CSF and sensory functions like vision and hearing. The functional studies have to
be carried out in avian species to understand the possible relationship of VT4R to each of the
particular function described above.

6. References
1. Acharjee S, Do-Rego JL, Oh DY, Moon JS, Ahn RS, Lee K, Bai DG, Vaudry H, Kwon
HB, Seong JY. 2004. Molecular cloning, pharmacological characterization, and
histochemical distribution of frog vasotocin and mesotocin receptors. J. Mol. Endocrinol.
33: 293-313.

2. Aguilera G, Pham Q, Rabadan-Diehl C. 1994. Regulation of pituitary vasopressin
receptors during chronic stress: relationship to corticotroph responsiveness. J.
Neuroendocrinol. 6: 299-304.
110

3. Aguilera G, Subburaju S, Young S, Chen J. 2008. The parvocellular vasopressinergic
system and responsiveness of the hypothalamic pituitary adrenal axis during chronic
stress. Prog. Brain Res. 170: 29-39.

4. Albers HE. 2011. The regulation of social recognition, social communication and
aggression: Vasopressin in the social behavior neural network. Horm. Behav.
doi:10.1016/j.yhbeh.2011.10.007

5. Aoyagi T, Koshimizu TA, Tanoue A. 2009. Vasopressin regulation of blood pressure and
volume: findings from V1a receptor-deficient mice. Kidney Int. 76: 1035-1039.

6. Arends JJA, Zeigler HP. 1986. Anatomical identification of an auditory pathway from a
nucleus of the lateral lemniscal system to the frontal telencephalon (nucleus basalis) of
the pigeon. Brain Res. 398: 375-381.

7. Baeyens DA, Cornett LE. 2006. The cloned avian neurohypophysial hormone receptors.
Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 143: 12-19.

8. Balment R, Warne J, Tierney M, Hazon N. 1993. Arginine vasotocin and fish
osmoregulation. Fish Physiol. Biochem. 11: 189-194.

9. Balment RJ, Lu W, Weybourne E, Warne JM. 2006. Arginine vasotocin a key hormone
in fish physiology and behaviour: a review with insights from mammalian models. Gen.
Comp. Endocrinol. 147: 9-16.

10. Bear MF, Connors BW, Paradiso MA (Ed.). (2001). Neuroscience: Exploring the brain [.
ISBN 0781739446] (4th ed.). Philedelphia, PA: Lippincott Williams & Wilkins.

11. Beery AK, Lacey EA, Francis DD. 2008. Oxytocin and vasopressin receptor distributions
in a solitary and a social species of tuco-tuco (Ctenomys haigi and Ctenomys sociabilis).
J. Comp. Neurol. 507: 1847-1859.

12. Bielsky IF, Young LJ. 2004a. Oxytocin, vasopressin, and social recognition in mammals.
Peptides 25: 1565-1574.

111

13. Bielsky IF, Hu SB, Szegda KL, Westphal H, Young LJ. 2004b. Profound impairment in
social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor
knockout mice. Neuropsychopharmacology 29: 483-493.

14. Bielsky IF, Hu SB, Young LJ. 2005a. Sexual dimorphism in the vasopressin system: lack
of an altered behavioral phenotype in female V1a receptor knockout mice. Behav. Brain
Res. 164: 132-136.

15. Bielsky IF, Hu SB, Ren X, Terwilliger EF, Young LJ. 2005b. The V1a vasopressin
receptor is necessary and sufficient for normal social recognition: a gene replacement
study. Neuron 47: 503-513.

16. Birnbaumer M. 2000. Vasopressin receptors. Trends Endocrinol. Metab. 11: 406-410.

17. Bordeaux J, Welsh A, Agarwal S, Killiam E, Baquero M, Hanna J, Anagnostou V, Rimm
D. 2010. Antibody validation. BioTechniques 48: 197-209.

18. Boyd SK. 1997. Brain vasotocin pathways and the control of sexual behaviors in the
bullfrog. Brain Res. Bull. 44: 345-350.

19. Burry RW. 2000. Specificity controls for immunocytochemical methods. J. Histochem.
Cytochem. 48: 163-166.

20. Campbell P, Ophir AG, Phelps SM. 2009. Central vasopressin and oxytocin receptor
distributions in two species of singing mice. J. Comp. Neurol. 516: 321-333.

21. Cornett LE, Kirby JD, Vizcarra JA, Ellison JC, Thrash J, Mayeux PR, Crew MD, Jones
SM, Ali N, Baeyens DA. 2003. Molecular cloning and functional characterization of a
vasotocin receptor subtype expressed in the pituitary gland of the domestic chicken
(Gallus domesticus): avian homolog of the mammalian V1b-vasopressin receptor. Regul.
Pept. 110: 231-239.

22. Cross BA. 1983. The neurohypophysis, structure, function, and control Amsterdam,
Netherlands.

23. Csernus VJ. 2006. The avian pineal gland. Chronobiol. Int. 23: 329-339.
112

24. Davis PJ, Shih A, Lin HY, Martino LJ, Davis FB. 2000. Thyroxine promotes association
of mitogen-activated protein kinase and nuclear thyroid hormone receptor (TR) and
causes serine phosphorylation of TR. J. Biol. Chem. 275: 38032-38039.

25. Dellman HD. 1964. On the Structure of the Vascular Organ of the Terminal Lamina in
Poultry. Anat. Anz. 115: 174-183.

26. Do-Rego JL, Acharjee S, Seong JY, Galas L, Alexandre D, Bizet P, Burlet A, Kwon HB,
Luu-The V, Pelletier G, Vaudry H. 2006. Vasotocin and mesotocin stimulate the
biosynthesis of neurosteroids in the frog brain. J. Neurosci. 26: 6749-6760.

27. Dubbeldam JL. 2000. Motor control system. In Sturkie`s avian physiology, Anonymous
Academic Press: California; 83-100.

28. Duvernoy HM, Risold PY. 2007a. The circumventricular organs: an atlas of comparative
anatomy and vascularization. Brain Res. Rev. 56: 119-147.

29. Duvernoy HM, Risold P. 2007b. The circumventricular organs: An atlas of comparative
anatomy and vascularization. Brain Res. Rev. 56: 119-147.

30. Engelmann M, Landgraf R, Wotjak CT. 2004. The hypothalamic-neurohypophysial
system regulates the hypothalamic-pituitary-adrenal axis under stress: an old concept
revisited. Front. Neuroendocrinol. 25: 132-149.

31. Fahrenholz F, Jurzak M, Gerstberger R, Haase W. 1993. Renal and central vasopressin
receptors: immunocytochemical localization. Ann. N. Y. Acad. Sci. 689: 194-206.

32. Ferguson JN, Young LJ, Insel TR. 2002. The neuroendocrine basis of social recognition.
Front. Neuroendocrinol. 23: 200-224.

33. Ferris CF. 2000. Adolescent stress and neural plasticity in hamsters: a vasopressinserotonin model of inappropriate aggressive behaviour. Exp. Physiol. 85 Spec No: 85S90S.

113

34. Francis DD, Young LJ, Meaney MJ, Insel TR. 2002. Naturally occurring differences in
maternal care are associated with the expression of oxytocin and vasopressin (V1a)
receptors: gender differences. Journal of neuroendocrinology. 14: 349-53.

35. Ganong WF. 2000. Circumventricular organs: definition and role in the regulation of
endocrine and autonomic function. Clin. Exp. Pharmacol. Physiol. 27: 422-427.

36. Gerfen CR. 2004. Basal Ganglia. In The rat nervous system, Paxinos G (3 ed). Elsevier:
London; 458.

37. Gomez G, Celii A. 2008. The peripheral olfactory system of the domestic chicken:
physiology and development. Brain Res. Bull. 76: 208-216.

38. Goodson JL. 1998. Territorial aggression and dawn song are modulated by septal
vasotocin and vasoactive intestinal polypeptide in male field sparrows (Spizella pusilla).
Horm. Behav. 34: 67-77.

39. Guglielmone R. 1995. Cerebrospinal fluid-contacting neurons in the paraventricular
organ and in the spinal cord of the quail embryo: a fluorescence-histochemical study. Cell
Tissue Res. 281: 163-168.

40. Gunturkun O. 2000. Sensory Physiology: Vision. In Sturkie`s avian physiology,
Anonymous Academic Press: California; 1-20.

41. Hasunuma I, Toyoda F, Kadono Y, Yamamoto K, Namiki H, Kikuyama S. 2010.
Localization of three types of arginine vasotocin receptors in the brain and pituitary of the
newt Cynops pyrrhogaster. Cell Tissue Res. 342: 437-457.

42. Hasunuma I, Sakai T, Nakada T, Toyoda F, Namiki H, Kikuyama S. 2007. Molecular
cloning of three types of arginine vasotocin receptor in the newt, Cynops pyrrhogaster.
Gen. Comp. Endocrinol. 151: 252-258.

43. Holmes MC, Antoni FA, Aguilera G, Catt KJ. 1986. Magnocellular axons in passage
through the median eminence release vasopressin. Nature. 319, 326-329.

114

44. Insel TR, Wang ZX, Ferris CF. 1994. Patterns of brain vasopressin receptor distribution
associated with social organization in microtine rodents. J. Neurosci. 14: 5381-5392.

45. Johnson AK, Gross PM. 1993. Sensory circumventricular organs and brain homeostatic
pathways. FASEB J. 7: 678-686.

46. Jones RB, Roper TJ. 1997. Olfaction in the domestic fowl: a critical review. Physiol.
Behav. 62: 1009-1018.

47. Jurkevich A, Barth SW, Grossmann R. 1997. Sexual dimorphism of arg-vasotocin gene
expressing neurons in the telencephalon and dorsal diencephalon of the domestic fowl.
An immunocytochemical and in situ hybridization study. Cell Tissue Res. 287: 69-77.

48. Jurkevich A, Berghman LR, Cornett LE, Kuenzel WJ. 2008. Immunohistochemical
characterization of chicken pituitary cells containing the vasotocin VT2 receptor. Cell
Tissue Res. 333: 253-262.

49. Jurkevich A, Berghman LR, Cornett LE, Kuenzel WJ. 2005. Characterization and
immunohistochemical visualization of the vasotocin VT2 receptor in the pituitary gland
of the chicken, Gallus gallus. Gen. Comp. Endocrinol. 143: 82-91.

50. Kline RJ, O'Connell LA, Hofmann HA, Holt GJ, Khan IA. 2011. The distribution of an
AVT V1a receptor in the brain of a sex changing fish, Epinephelus adscensionis. J.
Chem. Neuroanat. 42: 72-88.

51. Kuenzel WJ, van Tienhoven A. 1982. Nomenclature and location of avian hypothalamic
nuclei and associated circumventricular organs. The Journal of comparative neurology.
206(3), 293-313

52. Kuenzel, W. J., and M. Masson. 1988. A Stereotaxic Atlas of the Brain of the Chick
(Gallus domesticus). Johns Hopkins Univ. Press, Baltimore, MD

53. Kuenzel WJ, Golden CD. 2006. Distribution and change in number of gonadotropinreleasing hormone-1 neurons following activation of the photoneuroendocrine system in
the chick, Gallus gallus. Cell Tissue Res. 325: 501-512.

115

54. Kuenzel WJ, Blahser S. 1994. Vasoactive intestinal polypeptide (VIP)-containing
neurons: distribution throughout the brain of the chick (Gallus domesticus) with focus
upon the lateral septal organ. Cell Tissue Res. 275: 91-107.

55. Kuenzel WJ, Blahser S. 1994. Vasoactive intestinal polypeptide (VIP)-containing
neurons: distribution throughout the brain of the chick (Gallus domesticus) with focus
upon the lateral septal organ. Cell Tissue Res. 275: 91-107.

56. Kuenzel WJ. 1989. Neuroanatomical Substrates Involved in the Control of Food Intake.
Poultry Science 68: 926-937.

57. Landgraf R, Neumann ID. 2004. Vasopressin and oxytocin release within the brain: a
dynamic concept of multiple and variable modes of neuropeptide communication.
Frontiers in neuroendocrinology. 25(3-4), 150-176.

58. Leung CH, Goode CT, Young LJ, Maney DL. 2009. Neural distribution of nonapeptide
binding sites in two species of songbird. The Journal of comparative neurology. 513(2),
197-208

59. Leung CH, Abebe DF, Earp SE, Goode CT, Grozhik AV, Mididoddi P, Maney DL. 2011.
Neural Distribution of Vasotocin Receptor mRNA in Two Species of Songbird.
Endocrinology 152: 4865-4881.

60. Liu Y, Curtis JT, Wang Z. 2001. Vasopressin in the lateral septum regulates pair bond
formation in male prairie voles (Microtus ochrogaster). Behav. Neurosci. 115: 910-919.

61. Mahlmann S, Meyerhof W, Hausmann H, Heierhorst J, Schonrock C, Zwiers H, Lederis
K, Richter D. 1994. Structure, function, and phylogeny of [Arg8]vasotocin receptors
from teleost fish and toad. Proc. Natl. Acad. Sci. U. S. A. 91: 1342-1345.

62. Malmierca MS, Merchan MA. 2004. Auditory system. In The rat nervous system,
Paxinos G (ed). Elsevier: London; 996.

63. Michel MC, Wieland T, Tsujimoto G. 2009. How reliable are G-protein-coupled receptor
antibodies? Naunyn Schmiedebergs Arch. Pharmacol. 379: 385-388.

116

64. Morel A, Lolait SJ, Brownstein MJ. 1993. Molecular cloning and expression of rat V1a
and V2 arginine vasopressin receptors. Regul. Pept. 45: 53-59.

65. Nair HP, Young LJ. 2006. Vasopressin and pair-bond formation: genes to brain to
behavior. Physiology (Bethesda) 21: 146-152.

66. Natesan A, Geetha L, Zatz M. 2002. Rhythm and soul in the avian pineal. Cell Tissue
Res. 309: 35-45.

67. Necker R. 2000. The avina ear and hearing. In Sturkie`s avian physiology, Whittow C
(ed). Academic Press: California; 21-38.

68. Ostrowski NL, Lolait SJ, Young WS,3rd. 1994. Cellular localization of vasopressin V1a
receptor messenger ribonucleic acid in adult male rat brain, pineal, and brain vasculature.
Endocrinology 135: 1511-1528.

69. Ostrowski NL, Lolait SJ, Bradley DJ, O'Carroll AM, Brownstein MJ, Young WS,3rd.
1992. Distribution of V1a and V2 vasopressin receptor messenger ribonucleic acids in rat
liver, kidney, pituitary and brain. Endocrinology 131: 533-535.

70. Paxinos G. 2004. The rat nervous system Elsevier: London.

71. Peter J, Burbach H, Adan RA, Lolait SJ, van Leeuwen FW, Mezey E, Palkovits M,
Barberis C. 1995. Molecular neurobiology and pharmacology of the vasopressin/oxytocin
receptor family. Cell. Mol. Neurobiol. 15: 573-595.

72. Phillips PA, Abrahams JM, Kelly J, Paxinos G, Grzonka Z, Mendelsohn FAO, Johnston
CI. 1988. Localization of vasopressin binding sites in rat brain by in vitro
autoradiography using a radioiodinated V1 receptor antagonist. Neuroscience 27: 749761.

73. Price CJ, Hoyda TD, Ferguson AV. 2008. The Area Postrema: A Brain Monitor and
Integrator of Systemic Autonomic State. The Neuroscientist 14: 182-194.

117

74. Reiner, A., Perkel, D. J., Bruce, L. L., Butler, A. B., Csillag, A., Kuenzel, W., et al.
(2004). Revised nomenclature for avian telencephalon and some related brainstem
nuclei. The Journal of Comparative Neurology, 473(3), 377-414.

75. Reiner A, Yamamoto K, Karten HJ. 2005. Organization and evolution of the avian
forebrain. Anat. Rec. A. Discov. Mol. Cell. Evol. Biol. 287: 1080-1102.

76. Rhodes KJ, Trimmer JS. 2006. Antibodies as valuable neuroscience research tools versus
reagents of mass distraction. J. Neurosci. 26: 8017-8020.

77. Rink E, Wullimann MF. 2002. Connections of the ventral telencephalon and tyrosine
hydroxylase distribution in the zebrafish brain (Danio rerio) lead to identification of an
ascending dopaminergic system in a teleost. Brain Res. Bull. 57: 385-387.

78. Robinzon B KT,Neldon HL, Kinzler SL. 1988. Distribution of immunoreactive
mesotocin and vasotocin in the brain and pituitary of chickens. Peptides. 9 (4): 829-833.

79. Rodriguez EM, Rodriguez S, Hein S. 1998. The subcommissural organ. Microsc. Res.
Tech. 41: 98-123.

80. Scarbrough K, Kirby JD, Cornett LE, Okimoto R. 2003. Chromosomal assignment and
mapping of the Vasotocin Receptor 1, homologue to the mammalian V1a and Vasotocin
Receptor 2 homologue to the mammalian V1b receptors in the domestic fowl. Anim.
Genet. 34: 393.

81. Sefton AJ, Bogdan D, Harvey A. 2004. Visual system. In The rat nervous system,
Paxinos G (ed). 1082.

82. Shu SY, Ju G, Fan LZ. 1988. The glucose oxidase-DAB-nickel method in peroxidase
histochemistry of the nervous system. Neurosci. Lett. 85: 169-171.

83. Strazielle N, Ghersi-Egea JF. 2000. Choroid plexus in the central nervous system:
biology and physiopathology. J. Neuropathol. Exp. Neurol. 59: 561-574.

84. Strazielle N, Mutin M, Ghersi-Egea JF. 2005. The choroid plexuses: a dynamic interface
between the blood and the cerebrospinal fluid. Morphologie 89: 90-101.
118

85. Szot P, Bale TL, Dorsa DM. 1994. Distribution of messenger RNA for the vasopressin
V1a receptor in the CNS of male and female rats. Brain Res. Mol. Brain Res. 24: 1-10.

86. Vigh B. 1970. Does the paraventricular organ have a receptor function? Ann. Endocrinol.
(Paris) 31: 659-663.

87. Volpi S, Rabadan-Diehl C, Aguilera G. 2004. Vasopressinergic regulation of the
hypothalamic pituitary adrenal axis and stress adaptation. Stress 7: 75-83.

88. Walsh KM, Kuenzel WJ. 1997. Effect of sulfamethazine on sexual precocity and
neuropeptide Y neurons within the tuberoinfundibular region of the chick brain. Brain
Res. Bull. 44: 707-713.

89. Wang Z, Young LJ, Liu Y, Insel TR. 1997. Species differences in vasopressin receptor
binding are evident early in development: comparative anatomic studies in prairie and
montane voles. J. Comp. Neurol. 378: 535-546.

90. Warne JM. 2001. Cloning and characterization of an arginine vasotocin receptor from the
euryhaline flounder Platichthys flesus. Gen. Comp. Endocrinol. 122: 312-319.

91. Winslow JT, Insel TR. 2004. Neuroendocrine basis of social recognition. Current opinion
in neurobiology. 14: 248-53.

92. Winslow JT, Hastings N, Carter CS, Harbaugh CR, Insel TR. 1993. A role for central
vasopressin in pair bonding in monogamous prairie voles. Nature 365: 545-548.

93. Young LJ, Winslow JT, Nilsen R, Insel TR. 1997. Species differences in V1a receptor
gene expression in monogamous and nonmonogamous voles: behavioral consequences.
Behav. Neurosci. 111: 599-605.

94. Young LJ, Nilsen R, Waymire KG, MacGregor GR, Insel TR. 1999. Increased affiliative
response to vasopressin in mice expressing the V1a receptor from a monogamous vole.
Nature 400: 766-768.

119

List of tables
Table 1: Comparison of rat vasopressin/oxytocin and chicken vasotocin receptors to human
vasopressin/oxytocin receptors
Species

Rats

Homologue Rats
in Chicken
VT2
V2
47
86

Homologue Rats
in Chicken
VT1
OT
57
91

Homologue
in Chicken
VT3
74

Subtype
Sequence
homology1
Organs

V1b
63
Brain,
pituitary

Pituitary

Kidney

Shell gland,
uterus

Brain,
pituitary,
uterus

Endometrium
and
myometrium
of shell gland

Physiology
and
behavior

ACTH
release

ACTH and
prolactin
release

Water
Oviposition
reabsorption

Release of
prolactin

Endometrial
contractions
in the uterus

1

The receptor subtypes proposed homologous to human vasopressin subtypes based upon their
amino acid sequence identity to human V1aR.
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Table 2: Amino acid identity (%) of chicken VT4R compared with mammals and other
members of vasotocin/oxytocin, vasotocin/mesotocin-isotocin receptor family to human
vasopressin V1a receptor (V1aR)
(A) Receptor

Accession No.

Species

Identity (%)

Vasopressin V1a
Vasopressin V1a
Vasopressin V1a
Vasopressin V1a
Vasopressin V1a
Vasopressin V1a
Vasotocin VT4
Vasotocin V1a
Vasotocin VT
Vasotocin V1a
Vasotocin V1a
Vasotocin
Vasotocin
Vasotocin
Vasotocin V1a1
Vasotocin V1a1

U19906
Z11690
D49730
L41502
GU954352
AF069304.2
EU124684.1
XP 002187321
AY277924.1
GU945196.1
AB274037
AF184966
AF517936
X76321
HQ662334.1
GQ981412

Homo sapiens (human)
Rattus norvegicus (rat)
Mus musculus (mice)
Ovis aries (sheep)
Microtus montanus (Meadow vole)
Microtus ochrogaster (Priarie vole)
Gallus gallus (chicken)
Taeniopygia guttata (Zebra finch)
Rana catesbeiana (Bull frog)
Taricha granulosa (Rough skin newt)
Cynops pyrrhogaster (Red bellied newt)
Platichthys flesus (flounder)
Haplochromis burtoni (cichlid)
Catostomus commersoni (white sucker)
Epinephelus adscensionis (rock hind)
Cyprinodon nevadensis amargosae
(pupfish)

100
80
82
82
83
82
69
66
68
68
67
63
63
61
61
59

Vasopressin V1b
Vasopressin V1b
Vasopressin V1b
Vasotocin VT2
Vasotocin V1b
Vasotocin V1b
Vasotocin V1b
Vasotocin V3/V1b
Vasotocin V1a2
Vasotocin V1a2

L37112
D45400
AF098867
AY008272
XP 002189484
XP 003212983
EF567079.1
AB284503
HQ141396
GQ981413

Homo sapiens (human)
Rattus norvegicus (rat)
Mus musculus (mice)
Gallus gallus (chicken)
Taeniopygia guttata (Zebra finch)
Meleagris gallopavo (Turkey)
Taricha granulosa (Rough skin newt)
Cynops pyrrhogaster (Red bellied newt)
Epinephelus adscensionis (rock hind)
Cyprinodon nevadensis amargosae
(pupfish)

54
50
53
53
54
53
52
53
63
60
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(B) Receptor

Accession No.

Species

Identity (%)

Vasopressin V2
Vasopressin V2
Vasopressin V2
Vasotocin VT1
Vasotocin V2
Vasotocin V2
Vasotocin V2
Vasotocin V2

L22206
Z11932
NM019404
AF147743
XP 002195418
XP 003202046
ABQ 23253
BAF 38755

Homo sapiens (human)
Rattus norvegicus (rat)
Mus musculus (mice)
Gallus gallus (chicken)
Taeniopygia guttata (Zebra finch)
Meleagris gallopavo (Turkey)
Rana catesbeiana (Bull frog)
Cynops pyrrhogaster (Red bellied newt)

42
41
41
48
46
47
45
43

Oxytocin OT
Oxytocin OT
Oxytocin OT
Oxytocin OT
Vasotocin VT3
Mesotocin
Mesotocin
Isotocin
Isotocin

X64878
U82440
X87986
U15280
AY833434
AY277925.1
DQ186599.1
X87783
GQ981415

Homo sapiens (human)
Macaca mulatta (rhesus monkey)
Ovis aries (sheep)
Rattus norvegicus (rat)
Gallus gallus (chicken)
Rana catesbeiana (Bull frog)
Taricha granulosa (Rough skin newt)
Catostomus commersoni (white sucker)
Cyprinodon nevadensis amargosae
(pupfish)

54
52
51
49
49
48
49
47
53
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Table 3: Abbreviations

APa
Bas
BO
CbI
CbIM
CC
DIP

Area postrema
Nucleus basorostralis pallii
Bulbus olfactorius
Nucleus cerebellaris internus
Nucleus cerebellaris intermedius
Canalis centralis
Nucleus dorsointermedius posterior
thalami
DLAmc Nucleus dorsolateralis anterior thalami
DMP
Nucleus dorsomedialis posterior thalami
DMA

Nucleus dorsomedialis anterior thalami

E
EW
GCt
GLv
LFB
HL

Entopallium
Nucleus of Edinger Westphal
Substantia grisea centralis
Nucleus geniculatus lateralis, pars
ventralis
Lateral forebrain bundle
Nucleus Habenularis lateralis

Hp

Hippocampus

Ico

Nucleus intercollicularis

IH

Nucleus inferioris hypothalami

Imc

Nucleus isthmi, pars magnocellularis

IN
IO

Nucleus infundibuli hypothalami
Nucleus isthmo-opticus

nXII
OMdl

Nucleus nervi hypoglossi
Nucleus nervi oculomotorii pars
dorsolateralis
Nucleus nervi oculomotorii pars
dorsomedialis
Nucleus nervi oculomotorii pars ventralis
Nucleus olivaris superior
Nucleus ovoidalis
Organum vasculosum lamina terminalis
Nucleus periventricularis hypothalami
Nucleus pontis lateralis
Nucleus pontis medialis

OMdm
OMv
OS
OV
OVLT
PHN
PL
PM

IP
Ipc
IS
HA
La
LC
LFS

Nucleus interpeduncularis
Nucleus isthmi, pars parvocellularis
Nucleus interstitialis
Hyperpallium apicale
Nucleus laminaris
Nucleus linearis caudalis
Lamina frontalis superior

LFSM Lamina frontalis suprema
LLd
Nucleus lemnisci lateralis, pars
dorsalis
LLi
Nucleus lemnisci lateralis, pars
ventralis
LSO
Lateral septal organ
MCC Nucleus magnocellularis cochlearis
ME
Median eminence
MLd
Nucleus mesencephalicus lateralis
Mn V
MnV
IId
Mn
VIIv
Mn X

Nucleus motorius nervi trigemini
Nucleus motorius nervi facialis,
pars dorsalis
Nucleus motorius nervi facialis,
pars ventralis
Nucleus motorius dorsalis nervi
vagi
HpC
Hippocampal commissure(formerly
the bed nucleus of pallial
commissure)
nPrV Nucleus sensorius principalis nervi
trigemini
nVI
Nucleus nervi abducentis
nIX-X Nucleus nervi glossopharyngei et
nucleus motorius dorsalis nervi vagi
SCd
Nucleus subceruleus dorsalis
SCE
Stratum cellulare externum
SCv

Nucleus subceruleus ventralis

SCO
SG
SGP
SLu
SNc
SOe
SOv

Subcommissural organ
Substantia gelatinosa Rolandi
Stratum griesum periventriculare
Nucleus semilunaris
Substantia nigra
Nucleus supraopticus, pars externus
Nucleus supraopticus, pars ventralis
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POP
GP
PVN
PVO
R
RgC
ROT
RPgc
RpgI
RSd
RST
Ru
S

Nucleus preopticus periventricularis
Globus pallidus
Nucleus paraventricularis magnocellularis
(Paraventricular nucleus)
Paraventricular organ
Nucleus raphe
Nucleus reticularis gigantocellularis
Nucleus Rotundus
Nucleus reticularis pontis caudalis
Nucleus reticularis paragigantocellularis
lateralis
Nucleus reticularis superior
Nucleus reticularis subtrigerminalis
Nucleus ruber
Nucleus tractus solitarii

SL
SM
SpL

Nucleus septalis lateralis
Nucleus septalis medialis
Nucleus spiriformis medialis

SS
SSO
STO
VeD
VeL
VeM

Nucleus supraspinalis
Subseptal organ
Subtrochlear organ
Nucleus vestibularis descendens
Nucleus vestibularis lateralis
Nucleus vestibularis medialis

VeS
VTA
VO
VL

Nucleus vestibularis superior
Ventral tegmental area
Ventriculus olfactorius
Ventriculus lateralis
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Table 4
(a) Intensity of VT4R immunoreactivity in neurons
Region
Telencephalic regions
LFB: Lateral forebrain bundle
POP: Nucleus preopticus periventricularis
GP:Globus pallidus
Thalamic regions
DLAmc: Nucleus dorsolateralis anterior thalami
DMA: Nucleus dorsomedialis anterior thalami
DMP: Nucleus dorsomedialis posterior thalami
DIP: Nucleus dorsointermedius posterior thalami
HL: Nucleus Habenularis lateralis
GLv: Nucleus geniculatus lateralis
ROT: Nucleus Rotundus
RSd: Nucleus reticularis superior
SCE: Stratum cellulare externum
Hypothalamic regions
PHN: Nucleus periventricularis hypothalami
PVN: Paraventricular nucleus
SOe/Sov: Nucleus supraopticus (externus, ventralis)
Mesencephalic regions
GCt: Substantia grisea centralis
ICo: Nucleus intercollicularis
Imc: Nucleus isthmi, pars magnocellularis
IP: Nucleus interpeduncularis
Ipc: Nucleus isthmi, pars parvocellularis
MLd: Dorsal nucleus mesencephalicus lateralis
MPv: Ventral nucleus mesencephalicus profundus
VTA: Ventral tegmental area
Pontine regions
EW: Nucleus of Edinger Westphal
IO: Nucleus isthmo-opticus
La: Nucleus laminaris
LLd/LLi: Nucleus lemnisci lateralis (dorsalis, ventralis)
MCC: Nucleus magnocellularis cochlearis
Mn V: Nucleus motorius nervi trigemini
Mn VIId: Nucleus motorius nervi facialis, pars dorsalis
Mn VIIv: Nucleus motorius nervi facialis, pars ventralis
nVI: Nucleus nervi abducentis
nPr V: Nucleus sensorius principalis nervi trigemini
OMdl: Nucleus nervi oculomotorii pars dorsolateralis
OMdm: Nucleus nervi oculomotorii pars dorsomedialis
OMv: Nucleus nervi oculomotorii pars ventralis

Intensity
++
+++
+++
+++
++
++
++
+
++
++
++
++
+++
+++
++
+++
+++
+++
++
++
++
++
++
+++
+++
+++
+
+++
++
++
++
+++
++
+++
+++
+++
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OS: Nucleus olivaris superior
++
PL/PM: Nucleus pontis (lateralis, medialis)
+
R: Nucleus raphe
+
RPgc: Nucleus reticularis pontis caudalis
+++
RpgI: Nucleus reticularis paragigantocellularis lateralis
+++
SCd/SCv: Nucleus subceruleus (dorsalis, ventralis)
+
SNc: Substantia nigra
++
Cerebellar regions
Purkinje cell layer
+
Cerebellar nuclei
+++
Medullary regions
MnX: Nucleus motorius dorsalis nervi vagi
++
nIX-X: Nucleus nervi glossopharyngei et nucleus
+++
motorius dorsalis nervi vagi
nXII: Nucleus nervi hypoglossi
+++
RST: Nucleus reticularis subtrigerminalis
++
S: Nucleus tractus solitarii
++
SS: Nucleus supraspinalis
+++
VeD: Nucleus vestibularis descendens
+++
VeL/VeM: Nucleus vestibularis (lateralis, medialis)
+++
VeS: Nucleus vestibularis superior
++
Intensity in neurons was evaluated: Oculomotor neurons (+++, strong), isthmus nucleus (++,
moderate), pontis nucleus (+, weak)
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(b) Intensity of VT4R immunoreactivity in glial cells
Region
Intensity
Telencephalic regions
Bas: Nucleus basorostralis pallii
+++
BO: Bulbus olfactorius
++++
E: Entopallium
+++
HA: Hyperpallium apicale
+++
LFS:Lamina frontalis superior
+++
LFSM: Lamina frontalis suprema
+++
HpC: Hippocampal commissure, formerly NCPa
++++
OVLT: Organum vasculosum lamina terminalis
++++
SL: Nucleus septalis lateralis
+++
SM: Nucleus septalis medialis
+++
VO: Ventriculus olfactorius
++++
Thalamic regions
OV: Nucleus ovoidalis
+++
P: Pineal gland
++++
PC: Choroid plexus
++++
SCO: Subcommissural organ
++++
SGP: Stratum griesum periventriculare
+++
SSO: Subseptal organ (subfornical organ)
++++
Hypothalamic regions
IH: Nucleus inferioris hypothalami
++++
IN: Nucleus infundibuli hypothalami(arcuate nucleus)
++++
IS: Nucleus interstitialis
+++
PVO: Paraventricular organ
++++
ME: Median eminence
++++
Pontine regions
STO: Subtrochlear organ
++++
Cerebellar regions
Molecular layer
+++
Medullary regions
APa: Area postrema
++++
CC: Canalis centralis
++++
Intensity in glial cells was evaluated: Molecular layer of cerebellum (+++, strong) and
circumventricular organs (++++, intense).
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Figure legends:
Figure 1: (A) Amino acid sequence of the VT4R showing the N terminal peptide sequence
highlighted in red. (B) Amino acid alignment of the synthesized peptide with the chicken
VT4R.
Figure 2: Antiserum specificity of chicken vasotocin receptor (VT4R) was determined using
Western Blot analysis. (A) The antibody shows a single band at 47kDa as predicted by molecular
weight marker (M) in hypothalamic region (H), septal region (SL), pituitary tissues (P) and in
HeLa cells transfected with expression vector encoding the chicken VT4R cDNA (C2). The
absence of band was found with HeLa cells transfected with pGEM7Z plasmid (C1). (B)
Specificity test of antibody using peptide blocking experiments in membrane protein extracts
from the chicken hypothalamic tissues (H). The antibody at 1:1000 dilution was preadsorbed
with 5 µg (P1) and 20 µg (P2) of immunogenic peptides prior to application in the Western Blot.
Figure 3: The antibody was validated with a peptide competition assay in brain tissue sections
using immunohistochemistry . Sections A and D show the paraventricular nucleus and median
eminence, respectively, immunostained for neurons and glia using the VT4R antibody at 1:2000
dilution. The antibody was preadsorbed with 10 µg of peptide (B, E) and 50 µg of peptide (C,
F). The peptide competition assay was performed with perikarya (A-C) and glial cells (D-F).
Scale bars: 12 µm (B, C), 50µm (A), 100 µm (E), 300 µm (D, F).
Figure 4: Immunohistochemical detection of chicken vasotocin receptor (VT4R) in transfected
HeLa cells. HeLa cells transfected with chicken VT4R as detected by antibody VT4 #1 (A).
VT4R immunolabelled in the cytoplasm of cell profiles (B, C). VT4R immunoreactive cells and
processes are stained in red and nuclei counterstained with DAPI (C).

The absence of
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immunoreactivity in HeLa cells transfected with pGEM7Z (D), HeLa cells transfected with
expression vector encoding chicken VT1 cDNA (E), VT2 cDNA (F) and VT3 cDNA (G). Scale
bars 10µm (A, B, C), 15 µm (G), 20µm (D, E), 35µm (F).
Figure 5: Schematic representation of VT4R immunoreactivity in coronal brain sections arranged
from rostral to caudal. The distribution of VT4R are illustrated as perikarya (

) and glial cells (

). The plates are modified from Kuenzel and Masson, 1988. See Table 3 for abbreviations
and Table 4 for intensity of staining observed in different regions of the brain. Scale bars: 1cm.
Figure 6: Densely immunoreactiveVT4R in hypothalamic neurons and in glia. Schematic
diagram of chicken coronal plates modified from Kuenzel and Masson, 1988 (A, B). VT4R
immunoreactive perikarya in supraoptic nucleus (C), paraventricular nucleus (D). and glial cells
in hippocampus (E). Scale bars: 50 µm.
Figure 7: VT4R immunoreactive glial cell staining in olfactory lobes, dorsal septum and
mediobasal hypothalamus. A-C. Schematic diagrams of coronal plates A13.8 to A5.6 modified
from Kuenzel and Masson, 1988. D. Intense VT4R immunoreactivity of glial cells in olfactory
lobes surrounding the olfactory ventricle. E. Dense glial elements present in the dorsal septum
moving horizontally and in nucleus inferioris hypothalami and nucleus infundibuli hypothalami
(F). Scale bars: 300 µm (D), 50 µm (F), 20 µm (E).
Figure 8: Dense immunoreactive VT4Rs in neurons associated with motor pathways. Schematic
diagrams of coronal plates A13.4 to A3.6 (A, C). Intense immunoreactivity in globus pallidus
(B) and substantia nigra (D). Scale bars: 50 µm (B), 12 µm (D).
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Figure 9: VT4R immunostaining in neurons of the third and sixth cranial nerves. Schematic
diagram of coronal plates A3.4 (A) and P0.4 (C). Intense immunoreactive VT4Rs in Edinger
Westphal nucleus (B), oculomotor nucleus sub-nuclei (B) and abducens nucleus (D). Scale bars:
100 µm (B), 12 µm (D).
Figure 10: Dense immunoreactive VT4Rs in neurons associated with the eighth cranial nerve.
Schematic diagram of coronal plate P1.0 (A). Dense neuronal staining in magnocellular cochlear
nucleus (B) and moderate immunostaining in the dorsal portion of the vestibular nucleus (C).
Scale bars: 50 µm (B, C).
Figure 11: VT4R immunoreactivity in neurons involved in beak function.

Schematic diagram

of coronal sections A 0.8 and A 0.2 (I, A, B). Intense VT4R perikarya staining in the basorostral
pallial nucleus (II). Moderate immunoreactivity of VT4R in neurons of the principal nucleus of
the trigerminal nerve (C), motor nucleus of trigerminal nerve (D), dorsal portion of motor
nucleus of facial nerve (E). Scale bars: 100 µm (C), 50 µm (D, II), 12 µm (E).
Figure 12: Photomicrograph of VT4R immunoreactive staining in the cerebellum. Diagrammatic
representation of cerebellum in coronal plate A3.4 (A) of the chick brain atlas. Photomicrograph
of VT4R immunoreactive perikarya of purkinje cells (B), Berghmann glial cell immunostained
with VT4R in cerebellum (C) and VT4R immunolabelled cells in nucleus cerebellaris internalis
(CbI) (D). Scale bars: 100 µm (B), 50 µm (C, D).
Figure 13: Photomicrographs of VT4R immunoreactivity in circumventricular organs.
(A) Schematic plate deciphering the circumventricular organs in chicken (Reproduced from
Kuenzel, 1982) (B) Schematic plate A6.2 showing the choroid plexus of chick brain atlas,
modified from Kuenzel and Masson, 1988. (C) Intense glial cell labelling in choroid plexus
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(PCV-III) with VT4R. (D) VT4R immunoreactive glial cells observed in lateral septal organ (E)
organsum vasculosum lamini terminalis and ventral to the nucleus of the Hippocampal
commissure (HpC) formerly known as the nucleus of bed pallial commissure. (F) High
maginification of VT4R glial cells stained in subseptal organ (SSO). (G) Low magnification
image of VT4R immunolabelled in subcommissural organ (SCO). (H) High magnification
image of paraventricular organ (PVO) showing the VT4R immunoreactivity. (I) Low power
image of median eminence (ME) showing VT4R immunoreactive tanycytes.

(J)

Photomicrograph of pineal gland (PIN) showing glial cells immunolabelled for VT4R. Low
magnification photomicrographs of subtrochlear organ (STO) (K) and Area postrema (APa) (L)
showing VT4R immunoreactivity with subependymal glial cells. Scale bars: 50 µm (C-F), 100
µm (G, I, L), 12 µm (H, J), 300 µm (K).
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IV. CONCLUSIONS:
The most recently cloned chicken vasotocin receptor, VT4R shares 69% amino acid homology
with its mammalian counterpart, V1aR, a vasopressin receptor found in the mammalian brain.
The current study utilized an antibody to the VT4R and the technique of immunocytochemistry
in order to ascertain the distribution of the VT4R in the avian brain and pituitary gland. The
VT4R is present primarily in the cephalic lobe of the anterior pituitary and is associated with
corticotropes and gonadotropes. Of interest is that the homologous receptor in rats, the V1aR, of
rats is co-localized only in gonadotropes and not in corticotropes. The distribution of VT4R in
brain is widespread similar to mammals. Some of the neurons densely stained with VT4Rs were
observed in the paraventricular nucleus, supraoptic nucleus, Edinger Westphal nucleus,
oculomotor nucleus, magnocellular cochlear and hypoglossal nuclei.

The striking contrast

among the avian brain and mammalian brain was the densely stained VT4R in glial cells of the
avian brain. The functions of receptor were suggested to be associated with the regulation of
stress responses, body water regulation and involvement with nuclei associated with the eighth
and third cranial nerves. In conclusion, the present study determined the distribution of VT4R in
brain and pituitary gland of the chicken and addressed the possible functions of the receptor. A
major, proposed function of the VT4R in chickens is to serve in stress related neural pathways.
Chickens could serve as an animal model to determine the mechanism the VT4R plays in the
stress pathway of birds.
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